==> Achilles_fitness_decrease_counts.csv <==
Pathway,Count
22RV1-prostate,113
697-haematopoietic and lymphoid tissue,230
786O-kidney,74
A1207-central nervous system,115
A172-central nervous system,97
A204-soft tissue,64
A2058-skin,162
A549-lung,61
A673-bone,137

==> Achilles_fitness_increase_counts.csv <==
Pathway,Count
22RV1-prostate,30
697-haematopoietic and lymphoid tissue,65
786O-kidney,95
A1207-central nervous system,183
A172-central nervous system,74
A204-soft tissue,120
A2058-skin,61
A549-lung,91
A673-bone,58

==> Aging_Perturbations_from_GEO_down_counts.csv <==
Pathway,Count
Rat liver 4 months vs 12 months GSE11097 aging:192,279
Rat liver 4 months vs 12 months GSE11097 aging:190,299
Human brain (frontal cortex) 55 years vs 82 years GSE53890 aging:229,287
Mouse muscle 70 days vs 720 days GDS4904 aging:85,261
Human CD4+Tlyphocytes 40 years vs 52 years GSE62373 aging:177,359
Mouse bone marrow adipocyte 14 months vs 18 months GSE25905 aging:296,329
Human CD4+Tlyphocytes 61 years vs 72 years GSE62373 aging:184,363
Mouse liver 3 months vs 12 months GDS1990 aging:128,250
Mouse inguinal fat 5 months vs 24 months GSE25325 aging:280,276

==> Aging_Perturbations_from_GEO_up_counts.csv <==
Pathway,Count
Rat liver 4 months vs 12 months GSE11097 aging:192,321
Rat liver 4 months vs 12 months GSE11097 aging:190,301
Human brain (frontal cortex) 55 years vs 82 years GSE53890 aging:229,313
Mouse muscle 70 days vs 720 days GDS4904 aging:85,339
Human CD4+Tlyphocytes 40 years vs 52 years GSE62373 aging:177,241
Mouse bone marrow adipocyte 14 months vs 18 months GSE25905 aging:296,271
Human CD4+Tlyphocytes 61 years vs 72 years GSE62373 aging:184,237
Mouse liver 3 months vs 12 months GDS1990 aging:128,350
Mouse inguinal fat 5 months vs 24 months GSE25325 aging:280,324

==> Allen_Brain_Atlas_10x_scRNA_2021_counts.csv <==
Pathway,Count
Human Astro L1 FGFR3 SERPINI2 down,976
Human Astro L1 FGFR3 SERPINI2 up,101
Human Astro L1-6 FGFR3 AQP1 down,707
Human Astro L1-6 FGFR3 AQP1 up,45
Human Astro L1-6 FGFR3 PLCG1 down,880
Human Astro L1-6 FGFR3 PLCG1 up,64
Human Endo L2-5 NOSTRIN SRGN down,703
Human Endo L2-5 NOSTRIN SRGN up,43
Human Exc L2 LAMP5 KCNG3 down,49

==> Allen_Brain_Atlas_down_counts.csv <==
Pathway,Count
A4 noradrenergic cell group,300
"AOB, glomerular layer",300
"AOB, granular layer",300
"AOB, internal plexiform layer",300
"AOB, mitral cell layer",300
"AOB, outer plexiform layer",300
Abducens nucleus,300
Accessory facial motor nucleus,300
Accessory olfactory bulb,387

==> Allen_Brain_Atlas_up_counts.csv <==
Pathway,Count
A4 noradrenergic cell group,301
"AOB, glomerular layer",301
"AOB, granular layer",301
"AOB, internal plexiform layer",301
"AOB, mitral cell layer",301
"AOB, outer plexiform layer",301
Abducens nucleus,301
Accessory facial motor nucleus,301
Accessory olfactory bulb,379

==> ARCHS4_Cell-lines_counts.csv <==
Pathway,Count
22RV1,2395
293F,2395
A172,2395
A375,2395
A431,2395
A549,2395
A673,2395
ASPC1,2395
BEAS2B,2395

==> ARCHS4_IDG_Coexp_counts.csv <==
Pathway,Count
PRKAG1 IDG kinase ARCHS4 coexpression,299
PRKAB1 IDG kinase ARCHS4 coexpression,299
ADCK2 IDG kinase ARCHS4 coexpression,299
ADCK5 IDG kinase ARCHS4 coexpression,299
ALPK3 IDG kinase ARCHS4 coexpression,299
ADCK4 IDG kinase ARCHS4 coexpression,299
ALPK2 IDG kinase ARCHS4 coexpression,299
BCKDK IDG kinase ARCHS4 coexpression,299
CAMKV IDG kinase ARCHS4 coexpression,299

==> ARCHS4_Kinases_Coexp_counts.csv <==
Pathway,Count
AKT1 human kinase ARCHS4 coexpression,299
AKT2 human kinase ARCHS4 coexpression,299
AKT3 human kinase ARCHS4 coexpression,299
CDC42BPA human kinase ARCHS4 coexpression,299
CDC42BPB human kinase ARCHS4 coexpression,299
CDC42BPG human kinase ARCHS4 coexpression,299
CIT human kinase ARCHS4 coexpression,299
DMPK human kinase ARCHS4 coexpression,299
GRK1 human kinase ARCHS4 coexpression,299

==> ARCHS4_TFs_Coexp_counts.csv <==
Pathway,Count
NFYA human tf ARCHS4 coexpression,299
ARX human tf ARCHS4 coexpression,299
HOXA11 human tf ARCHS4 coexpression,299
SOX8 human tf ARCHS4 coexpression,299
ZFX human tf ARCHS4 coexpression,299
DLX6 human tf ARCHS4 coexpression,299
ETV1 human tf ARCHS4 coexpression,299
PAX6 human tf ARCHS4 coexpression,299
TEAD3 human tf ARCHS4 coexpression,299

==> ARCHS4_Tissues_counts.csv <==
Pathway,Count
ADIPOSE (BULK TISSUE),2316
ADRENAL GLAND,2316
ALPHA CELL,2316
ALVEOLAR CELL TYPE II,2316
ALVEOLAR MACROPHAGE,2316
AMNIOTIC FLUID,2316
ASTROCYTE,2316
ATRIUM,2316
BASAL CELL,2316

==> Azimuth_Cell_Types_2021_counts.csv <==
Pathway,Count
Acinar CL0002064,10
Activated Stellate CL0002410,10
Adventitial Fibroblast CL0000057,10
Airway Smooth Muscle UBERON0004225,10
Alpha Islet Cell CL0000171,10
Alveolar Epithelial Type 1 CL0002062,10
Alveolar Epithelial Type 2 CL0002063,13
Alveolar Fibroblast CL0000057,10
Artery UBERON0001637,10

==> BioCarta_2013_counts.csv <==
Pathway,Count
DEATH PATHWAY,33
TCAPOPTOSIS PATHWAY,11
CCR3 PATHWAY,23
NEUTROPHIL PATHWAY,8
ALTERNATIVE PATHWAY,9
PGC1A PATHWAY,24
PML PATHWAY,17
CALCINEURIN PATHWAY,19
RAN PATHWAY,5

==> BioCarta_2015_counts.csv <==
Pathway,Count
acetylation and deacetylation of rela in nucleus,5
actions of nitric oxide in the heart,42
activation of camp-dependent protein kinase pka,29
activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor,43
activation of pkc through g-protein coupled receptors,11
adp-ribosylation factor,29
agrin in postsynaptic differentiation,47
akap95 role in mitosis and chromosome dynamics,14
akt signaling pathway,18

==> BioCarta_2016_counts.csv <==
Pathway,Count
Classical Complement Pathway Homo sapiens h classicPathway,15
Lectin Induced Complement Pathway Homo sapiens h lectinPathway,13
Alternative Complement Pathway Homo sapiens h alternativePathway,10
Inhibition of Matrix Metalloproteinases Homo sapiens h reckPathway,8
Reversal of Insulin Resistance by Leptin Homo sapiens h leptinPathway,10
Eicosanoid Metabolism Homo sapiens h eicosanoidPathway,23
Mechanism of Acetaminophen Activity and Toxicity Homo sapiens h AcetaminophenPathway,7
Regulators of Bone Mineralization Homo sapiens h npp1Pathway,11
Platelet Amyloid Precursor Protein Pathway Homo sapiens h plateletAppPathway,14

==> BioPlanet_2019_counts.csv <==
Pathway,Count
2-LTR circle formation,5
4-1BB-dependent immune response,20
ABC transporters,47
ABCA transporters in lipid homeostasis,17
ACE inhibitor pathway,17
ADP signalling through P2Y purinoceptor 1,6
ADP signalling through P2Y purinoceptor 12,27
ADP-ribosylation factor,29
AKAP95 role in mitosis and chromosome dynamics,15

==> BioPlex_2017_counts.csv <==
Pathway,Count
ATXN2,19
ARSA,13
MED20,13
TCEAL1,29
PRPF19,37
MYF6,11
SEMG2,20
KLHL10,32
C5orf34,13

==> Cancer_Cell_Line_Encyclopedia_counts.csv <==
Pathway,Count
NCIH810 LUNG,315
MEG01 HAEMATOPOIETIC AND LYMPHOID TISSUE,248
COV434 OVARY,278
PECAPJ49 UPPER AERODIGESTIVE TRACT,46
PC3 PROSTATE,83
NCO2 HAEMATOPOIETIC AND LYMPHOID TISSUE,231
SW900 LUNG,41
HS172T URINARY TRACT,150
VMCUB1 URINARY TRACT,119

==> CCLE_Proteomics_2020_counts.csv <==
Pathway,Count
22RV1 PROSTATE TenPx24,854
697 HAEMATOPOIETIC AND LYMPHOID TISSUE TenPx30,752
769P KIDNEY TenPx25,552
786O KIDNEY TenPx10,366
8305C THYROID TenPx30,730
8505C THYROID TenPx40,560
A101D SKIN TenPx38,964
A172 CENTRAL NERVOUS SYSTEM TenPx24,644
A204 SOFT TISSUE TenPx23,717

==> CellMarker_Augmented_2021_counts.csv <==
Pathway,Count
Proximal Tubular cell:Kidney,101
Ito Cell (Hepatic Stellate cell):Liver,6
Trophoblast cell:Endometrium,100
Primordial Germ cell:Germ,92
Epithelial cell:Corneal Epithelium,98
Cytotrophoblast:Placenta,98
Periosteum-derived Progenitor cell:Periosteum,101
Amnion Epithelial cell:Amniotic Membrane,86
Primitive Streak cell:Primitive Streak,98

==> ChEA_2013_counts.csv <==
Pathway,Count
PAX6-23342162-BETA-FORBRAIN-LENS-MOUSE,1001
SRY-25088423-EMBRYONIC GONADS-MOUSE,3083
HOXB4-20404135-EML-MOUSE,1824
GATA1-19941827-MEL-mouse,1834
SOX2-19030024-MESC-mouse,863
ELF1-17652178-JURKAT-HUMAN,133
NFIB-24661679-E16.5 LUNG-MOUSE,573
E2F4-17652178-JURKAT-HUMAN,1002
BMI1-19503595-MEFC-mouse,661

==> ChEA_2015_counts.csv <==
Pathway,Count
VDR 24763502 ChIP-Seq THP-1 Human,1288
ELK1 22589737 ChIP-Seq MCF10A Human,928
SPI1 23127762 ChIP-Seq K562 Human,1389
REST 21632747 ChIP-Seq MESC Mouse,2339
SUZ12 18555785 ChIP-Seq MESC Mouse,1058
STAT3 22323479 ChIP-Seq MACROPHAGE Mouse,38
CCND1 20090754 ChIP-ChIP RETINA Mouse,2137
JUN 26020271 ChIP-Seq SMOOTH MUSCLE Human,2000
SMAD1 18555785 ChIP-Seq MESC Mouse,610

==> ChEA_2016_counts.csv <==
Pathway,Count
BP1 19119308 ChIP-ChIP Hs578T Human,18
FOXP1 22492998 ChIP-Seq STRATIUM Mouse,26
E4F1 26484288 ChIP-Seq MOUSE EMBRYONIC FIBROBLAST Mouse,30
RBPJ 22232070 ChIP-Seq NCS Mouse,34
TCF21 23034159 ChIP-ChIP E13 GONADS Rat,37
GATA1 22025678 ChIP-Seq K562 Human,38
HOXA2 22223247 ChIP-Seq E11.5 EMBRYO Mouse,38
STAT3 22323479 ChIP-Seq MACROPHAGE Mouse,38
TP63 17297297 ChIP-ChIP HaCaT Human,40

==> ChEA_2022_counts.csv <==
Pathway,Count
BP1 19119308 ChIP-ChIP Hs578T Human,18
FOXP1 22492998 ChIP-Seq STRATIUM Mouse,16
E4F1 26484288 ChIP-Seq MOUSE EMBRYONIC FIBROBLAST Mouse,17
RBPJ 22232070 ChIP-Seq NCS Mouse,24
TCF21 23034159 ChIP-ChIP E13 GONADS Rat,22
GATA1 22025678 ChIP-Seq K562 Human,27
HOXA2 22223247 ChIP-Seq E11.5 EMBRYO Mouse,23
STAT3 22323479 ChIP-Seq MACROPHAGE Mouse,32
TP63 17297297 ChIP-ChIP HaCaT Human,34

==> Chromosome_Location_counts.csv <==
Pathway,Count
chr16q,5
chr5q23,86
chr16q24,129
chr8q24,239
chr4p,3
chr13q11,24
chr7p21,60
chr10q23,148
chr13q13,50

==> Chromosome_Location_hg19_counts.csv <==
Pathway,Count
chr6 ssto hap7,190
chr16,1113
chr6 cox hap2,235
chr4,1031
chrY,141
chr20,757
chr19 gl000209 random,9
chrUn gl000220,31
chr7 gl000195 random,5

==> ClinVar_2019_counts.csv <==
Pathway,Count
4p partial monosomy syndrome,6
achromatopsia,5
acute lymphoid leukemia,7
acute myeloid leukemia,20
adult junctional epidermolysis bullosa,5
age-related macular degeneration,13
aicardi goutieres syndrome,5
alpha-dystroglycan related dystrophy,6
alzheimer's disease,10

==> CORUM_counts.csv <==
Pathway,Count
BCL6-HDAC4 complex (human),2
BCL6-HDAC5 complex (human),2
BCL6-HDAC7 complex (human),2
Multisubunit ACTR coactivator complex (human),4
6S-nuclear aryl hydrocarbon (Ah) receptor ligand-activated complex (mouse),2
BLOC-3 (biogenesis of lysosome-related organelles complex 3) (human),2
BLOC-2 (biogenesis of lysosome-related organelles complex 2) (human),3
MUS81-CDS1 complex (human),2
NCOR complex (human),6

==> COVID-19_Related_Gene_Sets_2021_counts.csv <==
Pathway,Count
100 gene most correlated to LDLRAD4 based on ARCHS4 co-expression,80
152 Down Genes from GEN3VA Mouse Lung; Accession: GSE19137 Platform: GPL1261 Entry 6,148
178 positive hits from CRISPR screen of Heaton et al. in A549-ACE2 cells,170
184 proteins up-regualated at 0h in SARS-CoV-2 infected cells from Bouhaddou et al. 2020,182
192 negative hits from CRISPR screen of Heaton et al. in A549-ACE2 cells,180
197 proteins down-regualated at 4h in SARS-CoV-2 infected cells from Bouhaddou et al. 2020,196
21 Positive hits from CRISPR screen from Hoffmann et al. (PMID 32935098) in Huh-7.5 cells at 37 deg C,20
235 proteins up-regualated in SARS-CoV-2 infected cells from Bouhaddou et al. 2020,233
238 proteins down-regualated  in SARS-CoV-2 infected cells from Bouhaddou et al. 2020,236

==> COVID-19_Related_Gene_Sets_counts.csv <==
Pathway,Count
COVID19-E protein host PPI from Krogan,6
COVID19-M protein host PPI from Krogan,30
COVID19-N protein host PPI from Krogan,15
COVID19-Nsp1 protein host PPI from Krogan,6
COVID19-Nsp10 protein host PPI from Krogan,14
COVID19-Nsp12 protein host PPI from Krogan,20
COVID19-Nsp13 protein host PPI from Krogan,40
COVID19-Nsp2 protein host PPI from Krogan,7
COVID19-Nsp4 protein host PPI from Krogan,8

==> Data_Acquisition_Method_Most_Popular_Genes_counts.csv <==
Pathway,Count
ChIP-seq,100
Data aggregation,100
GWAS,100
KO Mice Phenotyping,100
L1000 Expression Profiling,100
Literature,100
Mass Spectrometry,100
Microarray,100
Multiple Assays,100

==> dbGaP_counts.csv <==
Pathway,Count
"Aortic Aneurysm, Abdominal",3
Nasopharyngeal Neoplasms,4
Glioma,5
Carotid Stenosis,17
Intracranial Aneurysm,7
Optic Disk,8
Breast Neoplasms,57
Gout,12
"F8 protein, human [Supplementary Concept]",3

==> DepMap_WG_CRISPR_Screens_Broad_CellLines_2019_counts.csv <==
Pathway,Count
127399,337
143B,336
23132/87,468
253J,432
42-MG-BA,288
5637,287
59M,305
639V,302
647V,318

==> DepMap_WG_CRISPR_Screens_Sanger_CellLines_2019_counts.csv <==
Pathway,Count
22Rv1,187
23132/87,373
42-MG-BA,282
769-P,461
8-MG-BA,762
A-172,299
A-253,223
A-375,317
A-549,228

==> Descartes_Cell_Types_and_Tissue_2021_counts.csv <==
Pathway,Count
Acinar cells in Pancreas,91
Adrenocortical cells in Adrenal,12
AFP ALB positive cells in Placenta,251
AFP ALB positive cells in Spleen,251
Amacrine cells in Eye,9
Antigen presenting cells in Thymus,209
Astrocytes in Cerebellum,149
Astrocytes in Cerebrum,190
Astrocytes in Eye,85

==> Diabetes_Perturbations_GEO_2022_counts.csv <==
Pathway,Count
GSE151030 S273A Mm WAT Dn,125
GSE151030 S273A Mm WAT Up,85
GSE106295 DKO Mm Heart Up,174
GSE162037 Mrp4- Mm WAT Dn,163
GSE162037 Mrp4- Mm WAT Up,156
GSE149662 IRMOE Mm Muscle Dn,202
GSE101537 CBP-KO Mm Islet Dn,191
GSE149662 IRMOE Mm Muscle Up,180
GSE101537 CBP-KO Mm Islet Up,194

==> Disease_Perturbations_from_GEO_down_counts.csv <==
Pathway,Count
asthma DOID-2841 human GSE16032 sample 729,303
Type 1 diabetes mellitus C0011854 human GSE10586 sample 9,213
Diabetic Neuropathy C0011882 mouse GSE11343 sample 7,333
tibial muscular dystrophy DOID-9884 human GSE42806 sample 539,335
Cushing Syndrome C0010481 human GSE4060 sample 1,284
"Leukemia, Chronic T-Cell C2363142 human GSE5788 sample 74",313
Retinal damage C0235272 rat GSE1001 sample 312,279
schizophrenia DOID-5419 human GSE21935 sample 855,350
Infection by Yersinia enterocolitica C0238528 mouse GSE2973 sample 127,284

==> Disease_Perturbations_from_GEO_up_counts.csv <==
Pathway,Count
asthma DOID-2841 human GSE16032 sample 729,297
Type 1 diabetes mellitus C0011854 human GSE10586 sample 9,387
Diabetic Neuropathy C0011882 mouse GSE11343 sample 7,267
tibial muscular dystrophy DOID-9884 human GSE42806 sample 539,265
Cushing Syndrome C0010481 human GSE4060 sample 1,316
"Leukemia, Chronic T-Cell C2363142 human GSE5788 sample 74",287
Retinal damage C0235272 rat GSE1001 sample 312,321
schizophrenia DOID-5419 human GSE21935 sample 855,250
Infection by Yersinia enterocolitica C0238528 mouse GSE2973 sample 127,316

==> Disease_Signatures_from_GEO_down_2014_counts.csv <==
Pathway,Count
Actinic keratosis GSE2503,300
Acute Lung Injury GSE1871,300
Acute Lung Injury GSE10474,300
Adenocarcinoma of lung GSE1037,300
Adenoma GSE8514,300
Adenoma GSE4183,300
Alzheimer's Disease GSE1297,300
Alzheimer's Disease GSE5281,300
Anaplasmosis GSE2600,300

==> Disease_Signatures_from_GEO_up_2014_counts.csv <==
Pathway,Count
Actinic keratosis GSE2503,300
Acute Lung Injury GSE1871,300
Acute Lung Injury GSE10474,300
Adenocarcinoma of lung GSE1037,300
Adenoma GSE8514,300
Adenoma GSE4183,300
Alzheimer's Disease GSE1297,300
Alzheimer's Disease GSE5281,300
Anaplasmosis GSE2600,300

==> DisGeNET_counts.csv <==
Pathway,Count
"46, XX Testicular Disorders of Sex Development",9
"46, XY Disorders of Sex Development",19
"46, XY female",20
"46,XY partial gonadal dysgenesis",11
"5,10-Methylenetetrahydrofolate reductase deficiency",19
"Abnormalities, Drug-Induced",5
"Abortion, Habitual",6
"Abortion, Tubal",109
"Achondrogenesis, type IB (disorder)",5

==> DrugMatrix_counts.csv <==
Pathway,Count
(+)-Pulegone-200 mg/kg in CMC-Rat-Kidney-1d-dn,317
(+)-Pulegone-200 mg/kg in CMC-Rat-Kidney-1d-up,283
(+)-Pulegone-200 mg/kg in CMC-Rat-Kidney-3d-dn,312
(+)-Pulegone-200 mg/kg in CMC-Rat-Kidney-3d-up,288
(+)-Pulegone-200 mg/kg in CMC-Rat-Kidney-5d-dn,314
(+)-Pulegone-200 mg/kg in CMC-Rat-Kidney-5d-up,286
(R)-Bicalutamide-1400 mg/kg in CMC-Rat-Kidney-1d-dn,276
(R)-Bicalutamide-1400 mg/kg in CMC-Rat-Kidney-1d-up,324
(R)-Bicalutamide-1400 mg/kg in CMC-Rat-Kidney-3d-dn,277

==> Drug_Perturbations_from_GEO_2014_counts.csv <==
Pathway,Count
estradiol mus musculus gpl339 gse16854 chdir down,43
letrozole homo sapiens gpl3921 gse33366 chdir down,404
mifepristone homo sapiens gpl6947 gse39654 chdir down,298
tamoxifen homo sapiens gpl96 gds2367 chdir down,156
fluorouracil homo sapiens gpl550 zr-75-1 gds1627 chdir up,51
estradiol homo sapiens gpl570 gds3283 chdir up,6814
cisplatin homo sapiens gds3910 chdir up,1542
cyclophosphamide mus musculus gpl13209 gse27421 chdir up,96
colchicine homo sapiens gpl3386 gds1753 chdir down,161

==> Drug_Perturbations_from_GEO_down_counts.csv <==
Pathway,Count
tretinoin DB00755 mouse GSE31280 sample 2829,216
morphine 5288826 mouse GSE7762 sample 3489,387
"cytarabine, 2xEC50, 3 d 6253 human GSE6930 sample 3423",318
estradiol 5757 mouse GSE2889 sample 3608,431
curcumin 969516 human GSE10896 sample 3408,385
"cytarabine, EC50, 5 d 6253 human GSE6930 sample 3375",468
neocarzinostatin 5282473 human GSE1676 sample 3113,301
Etanercept DB00005 human GSE36177 sample 2596,223
Retinoic acid 444795 human GSE32161 sample 3237,241

==> Drug_Perturbations_from_GEO_up_counts.csv <==
Pathway,Count
tretinoin DB00755 mouse GSE31280 sample 2829,384
morphine 5288826 mouse GSE7762 sample 3489,213
"cytarabine, 2xEC50, 3 d 6253 human GSE6930 sample 3423",282
estradiol 5757 mouse GSE2889 sample 3608,169
curcumin 969516 human GSE10896 sample 3408,215
"cytarabine, EC50, 5 d 6253 human GSE6930 sample 3375",132
neocarzinostatin 5282473 human GSE1676 sample 3113,299
Etanercept DB00005 human GSE36177 sample 2596,377
Retinoic acid 444795 human GSE32161 sample 3237,359

==> DSigDB_counts.csv <==
Pathway,Count
dopamine,31
4-aminopyridine,36
acetaminophen,21
albendazole,21
alprazolam,27
amiodarone,46
amitriptyline,32
amoxapine,35
bisacodyl,23

==> Elsevier_Pathway_Collection_counts.csv <==
Pathway,Count
A-cell (X-like): Ghrelin and Nesfatin-1 Synthesis,15
Acid Secretion by Collecting Duct of Kidney Nephron,7
"Activin, Inhibin and Follistatin Action on Pituitary Gland",11
Adenosine Role in Sleep Regulation,9
Adipokines Production by Adipocyte,46
ADORA1/2A -> Exocytosis,15
ADORA2A/B -> Vasodilation,5
ADORA3 -> Mast-Cell Degranulation,7
ADRA1 -> Ion Channels,17

==> ENCODE_and_ChEA_Consensus_TFs_from_ChIP-X_counts.csv <==
Pathway,Count
NANOG CHEA,595
AR CHEA,1095
ETS1 ENCODE,156
ZC3H11A ENCODE,129
E2F6 ENCODE,3245
IRF8 CHEA,121
YY1 ENCODE,2753
CHD1 ENCODE,655
SRF ENCODE,299

==> ENCODE_Histone_Modifications_2013_counts.csv <==
Pathway,Count
GM12878 H3K36me3,187
HEE H3K4me3,925
K562 H3K4me3,3460
SKNSHRA H3K27me3,504
HEPG2 H3K27me3,150
HCF H3K4me3,925
PANC1 H3K27ac,1999
NHDFNEO H3K4me3,823
HMEC H3K27me3,90

==> ENCODE_Histone_Modifications_2015_counts.csv <==
Pathway,Count
H4K20me1 myotube hg19,2000
H3K9ac HepG2 hg19,2000
H3K27ac testis mm9,2000
H3K9me3 mammary epithelial cell hg19,2000
H3K4me3 K562 hg19,4606
H3K9me3 A549 hg19,2000
H3K27ac H1-hESC hg19,2000
H3K27ac A549 hg19,2991
H3K9ac myotube hg19,2000

==> ENCODE_TF_ChIP-seq_2014_counts.csv <==
Pathway,Count
PML K562,5326
P300 H1,2566
RFX5 HELA-S3,6678
E2F4 GM12878,3031
SP1 HEPG2,3534
CTCF H1,7157
NFKB GM19193,1190
TR4 HEPG2,737
CREB1 H1,5307

==> ENCODE_TF_ChIP-seq_2015_counts.csv <==
Pathway,Count
POLR2AphosphoS2 MEL cell line mm9,2000
STAT1 HeLa-S3 hg19,945
MAX HepG2 hg19,3158
CREB1 HepG2 hg19,1423
CTCF fibroblast of upper leg skin hg19,1665
TRIM28 U2OS hg19,2000
JUND MEL cell line mm9,257
EZH2 keratinocyte hg19,2000
MYOD1 C2C12 mm9,1026

==> Enrichr_Libraries_Most_Popular_Genes_counts.csv <==
Pathway,Count
Achilles fitness decrease,105
Achilles fitness increase,124
Aging Perturbations from GEO down,103
Aging Perturbations from GEO up,100
Allen Brain Atlas down,102
Allen Brain Atlas up,104
ARCHS4 Cell-lines,120
ARCHS4 IDG Coexp,100
ARCHS4 Kinases Coexp,110

==> Enrichr_Submissions_TF-Gene_Coocurrence_counts.csv <==
Pathway,Count
ADAMTS17,299
ADAMTS19,299
ADAR,299
ADNP,299
ADNP2,299
AEBP2,299
AFF1,299
AFF3,299
AFF4,299

==> Enrichr_Users_Contributed_Lists_2020_counts.csv <==
Pathway,Count
"+E2, CtS +E2, si10 -E2, si10",21
+ly regulated SILAC Cradiomyoctes,45
05 miR-TF genage,84
06 miR-TF agemap,86
1.5-FC Up,590
10 percent of the longest transcripts of the human genome,1812
100 genes for Ex 11,100
100 upregulated genes in Trophectoderm (GSE66507),100
1000 murine c10,874

==> Epigenomics_Roadmap_HM_ChIP-seq_counts.csv <==
Pathway,Count
H3K4me3 CD8 Memory Primary Cells,9655
H3K79me1 IMR90,2902
H3K4ac IMR90,6751
H3K4me1 CD4+ CD25int CD127+ Tmem Primary Cells,2991
H3K27ac iPS DF 19.11,7920
H3K9me3 Brain Cingulate Gyrus,115
H3K4me1 CD34 Cultured Cells,6532
H3K4me1 Adipose Nuclei,2902
H3K9me3 Adult Liver,240

==> ESCAPE_counts.csv <==
Pathway,Count
CHiP POU5F1-18700969,567
RAD21-21589869 DOWN,659
Protein POU5F1-19536159,2
Protein SALL4-19440552,6
CHiP KLF4-19030024,1502
CHiP SMAD1-18555785,610
CHiP NANOG-18700969,344
Protein NANOG-18454141,2
CHiP PRDM14-21183938,1758

==> FANTOM6_lncRNA_KD_DEGs_counts.csv <==
Pathway,Count
A1BG-AS1-ASO_G0268895_01-DEGs Up,345
A1BG-AS1-ASO_G0268895_01-DEGs Down,442
A1BG-AS1-ASO_G0268895_03-DEGs Up,711
A1BG-AS1-ASO_G0268895_03-DEGs Down,1308
AC004980.7-ASO_G0205485_01-DEGs Up,221
AC004980.7-ASO_G0205485_01-DEGs Down,647
AC004980.7-ASO_G0205485_03-DEGs Up,13
AC004980.7-ASO_G0205485_03-DEGs Down,12
AC005592.2-ASO_G0231185_02-DEGs Up,157

==> GeDiPNet_2023_counts.csv <==
Pathway,Count
1P36 Deletion Syndrome,5
22Q11 Deletion Syndrome,10
22Q11 Partial Monosomy Syndrome,9
22Q11.2 Deletion Syndrome,9
3M Syndrome,5
"46, XX Gonadal Dysgenesis",9
"46, XX Gonadal Sex Reversal",6
"46, XY Complete Gonadal Dysgenesis",10
"46, XY Disorder Of Sex Development",9

==> Gene_Perturbations_from_GEO_down_counts.csv <==
Pathway,Count
Pmp22 KO mouse GSE1947 sample 969,332
HIPK2 KD human GSE43881 sample 2873,336
Kdm6a KD mouse GSE45034 sample 1302,255
SMC3 KD human GSE38252 sample 2222,302
Nr3c1 KO mouse GSE23724 sample 3014,334
Mef2d KD mouse GSE47150 sample 366,271
RFWD2 KD human GSE27914 sample 1243,303
Kcnip3 KO mouse GSE16874 sample 1031,261
Runx1 KO mouse GSE2592 sample 277,289

==> Gene_Perturbations_from_GEO_up_counts.csv <==
Pathway,Count
Pmp22 KO mouse GSE1947 sample 969,268
HIPK2 KD human GSE43881 sample 2873,264
Kdm6a KD mouse GSE45034 sample 1302,345
SMC3 KD human GSE38252 sample 2222,298
Nr3c1 KO mouse GSE23724 sample 3014,266
Mef2d KD mouse GSE47150 sample 366,329
RFWD2 KD human GSE27914 sample 1243,297
Kcnip3 KO mouse GSE16874 sample 1031,339
Runx1 KO mouse GSE2592 sample 277,311

==> Genes_Associated_with_NIH_Grants_counts.csv <==
Pathway,Count
R01HL043339,4
R01DK054736,5
T32CA070083,4
R01GM078270,3
ZIAAG000928,14
R01AI020059,5
R37AI023081,18
R01DK097376,4
R01CA081157,7

==> GeneSigDB_counts.csv <==
Pathway,Count
19951989-Table2,28
16152586-Table1,14
15467184-Table3a,30
18081427-TableS7,556
18081427-TableS8,751
18302714-Figure1b,18
19408105-Table4,51
15467184-Table3b,29
18535662-TableS2a,978

==> Genome_Browser_PWMs_counts.csv <==
Pathway,Count
RGAGGAARY V$PU1 Q6,522
KRCTCNNNNMANAGC UNKNOWN,66
AAAYWAACM V$HFH4 01,264
YYCATTCAWW UNKNOWN,194
CYTAGCAAY UNKNOWN,153
CAGCTG V$AP4 Q5,1561
GGCNKCCATNK UNKNOWN,122
RRAGTTGT UNKNOWN,258
GATTGGY V$NFY Q6 01,1190

==> GlyGen_Glycosylated_Proteins_2022_counts.csv <==
Pathway,Count
G00031MO,27
G00406II,44
G00912UN,135
G01614ZM,22
G01650EU,34
G02030ZB,76
G02315DX,16
G02628JF,33
G02815KT,34

==> GO_Biological_Process_2013_counts.csv <==
Pathway,Count
protein secretion (GO:0009306),15
rRNA transcription (GO:0009303),13
positive regulation of DNA replication (GO:0045740),23
respiratory burst (GO:0045730),9
positive regulation of protein catabolic process (GO:0045732),20
positive regulation of DNA repair (GO:0045739),15
negative regulation of adenylate cyclase activity (GO:0007194),26
inhibition of adenylate cyclase activity by G-protein signaling (GO:0007193),13
regulation of transcription factor activity (GO:0051090),66

==> GO_Biological_Process_2015_counts.csv <==
Pathway,Count
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),14
retinoid metabolic process (GO:0001523),81
type B pancreatic cell proliferation (GO:0044342),8
CDP-diacylglycerol metabolic process (GO:0046341),14
cellular response to heat (GO:0034605),29
definitive hemopoiesis (GO:0060216),14
dendrite development (GO:0016358),35
amino sugar catabolic process (GO:0046348),13
negative regulation of lymphocyte mediated immunity (GO:0002707),25

==> GO_Biological_Process_2017b_counts.csv <==
Pathway,Count
tRNA modification (GO:0006400),38
minus-end-directed organelle transport along microtubule (GO:0072385),8
termination of mitochondrial transcription (GO:0006393),15
purine nucleotide interconversion (GO:0015950),32
regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903381),16
retinal metabolic process (GO:0042574),63
protein-tetrapyrrole linkage (GO:0017006),84
negative regulation of type III interferon production (GO:0034345),7
regulation of translation in response to stress (GO:0043555),22

==> GO_Biological_Process_2017_counts.csv <==
Pathway,Count
monocyte activation (GO:0042117),8
cobalamin metabolic process (GO:0009235),21
prostaglandin biosynthetic process (GO:0001516),12
prostaglandin metabolic process (GO:0006693),9
cyclooxygenase pathway (GO:0019371),11
chromatin silencing (GO:0006342),37
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),6
histone H3-K4 methylation (GO:0051568),14
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),6

==> GO_Biological_Process_2018_counts.csv <==
Pathway,Count
positive regulation of posttranscriptional gene silencing (GO:0060148),11
regulation of cell cycle process (GO:0010564),90
angiotensin-activated signaling pathway (GO:0038166),7
"DNA-templated transcription, termination (GO:0006353)",106
regulation of protein sumoylation (GO:0033233),17
regulation of cellular response to stress (GO:0080135),104
potassium ion import (GO:0010107),38
protein complex disassembly (GO:0043241),46
protein insertion into mitochondrial membrane (GO:0051204),8

==> GO_Biological_Process_2021_counts.csv <==
Pathway,Count
'de novo' posttranslational protein folding (GO:0051084),31
2-oxoglutarate metabolic process (GO:0006103),14
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),6
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),25
3'-UTR-mediated mRNA destabilization (GO:0061158),16
3'-UTR-mediated mRNA stabilization (GO:0070935),18
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015),5
5-phosphoribose 1-diphosphate metabolic process (GO:0046391),5
5S class rRNA transcription by RNA polymerase III (GO:0042791),6

==> GO_Biological_Process_2023_counts.csv <==
Pathway,Count
'De Novo' AMP Biosynthetic Process (GO:0044208),6
'De Novo' Post-Translational Protein Folding (GO:0051084),32
2-Oxoglutarate Metabolic Process (GO:0006103),14
3'-UTR-mediated mRNA Destabilization (GO:0061158),15
3'-UTR-mediated mRNA Stabilization (GO:0070935),18
3'-Phosphoadenosine 5'-Phosphosulfate Metabolic Process (GO:0050427),15
5S Class rRNA Transcription By RNA Polymerase III (GO:0042791),5
7-Methylguanosine RNA Capping (GO:0009452),5
7-Methylguanosine Cap Hypermethylation (GO:0036261),7

==> GO_Cellular_Component_2013_counts.csv <==
Pathway,Count
axon (GO:0030424),12
dendrite (GO:0030425),17
growth cone (GO:0030426),12
trans-Golgi network (GO:0005802),22
centrosome (GO:0005813),77
microtubule organizing center (GO:0005815),91
centriole (GO:0005814),10
spindle (GO:0005819),15
cytosol (GO:0005829),740

==> GO_Cellular_Component_2015_counts.csv <==
Pathway,Count
ribonucleoprotein granule (GO:0035770),111
plasma lipoprotein particle (GO:0034358),38
proteasome accessory complex (GO:0022624),17
cytosolic large ribosomal subunit (GO:0022625),52
cytoplasmic stress granule (GO:0010494),32
contractile ring (GO:0070938),9
H4 histone acetyltransferase complex (GO:1902562),16
plasma membrane raft (GO:0044853),58
TOR complex (GO:0038201),11

==> GO_Cellular_Component_2017b_counts.csv <==
Pathway,Count
"vacuolar proton-transporting V-type ATPase, V1 domain (GO:0000221)",11
extrinsic component of autophagosome membrane (GO:0097635),15
junctional sarcoplasmic reticulum membrane (GO:0014701),9
Barr body (GO:0001740),26
cytoplasmic ribonucleoprotein granule (GO:0036464),32
phagocytic vesicle lumen (GO:0097013),49
TEAD-2-YAP complex (GO:0071149),35
vacuolar proton-transporting V-type ATPase complex (GO:0016471),9
extrinsic component of periplasmic side of plasma membrane (GO:0031236),7

==> GO_Cellular_Component_2017_counts.csv <==
Pathway,Count
external side of plasma membrane (GO:0009897),124
"immunoglobulin complex, circulating (GO:0042571)",40
blood microparticle (GO:0072562),174
condensed chromosome kinetochore (GO:0000777),10
"condensed nuclear chromosome, centromeric region (GO:0000780)",6
mitochondrion (GO:0005739),921
centrosome (GO:0005813),401
mitochondrial respiratory chain complex III (GO:0005750),11
P-body (GO:0000932),87

==> GO_Cellular_Component_2018_counts.csv <==
Pathway,Count
platelet dense granule (GO:0042827),21
chromatoid body (GO:0033391),8
Golgi trans cisterna (GO:0000138),7
elongin complex (GO:0070449),8
telomerase holoenzyme complex (GO:0005697),22
chromosomal region (GO:0098687),76
lipid droplet (GO:0005811),64
centriole (GO:0005814),95
polysome (GO:0005844),63

==> GO_Cellular_Component_2021_counts.csv <==
Pathway,Count
9+0 non-motile cilium (GO:0097731),8
9+2 motile cilium (GO:0097729),57
90S preribosome (GO:0030686),13
acetylcholine-gated channel complex (GO:0005892),14
acrosomal membrane (GO:0002080),13
acrosomal vesicle (GO:0001669),48
actin cytoskeleton (GO:0015629),316
actin filament (GO:0005884),72
actin-based cell projection (GO:0098858),83

==> GO_Cellular_Component_2023_counts.csv <==
Pathway,Count
9+0 Non-Motile Cilium (GO:0097731),8
9+2 Motile Cilium (GO:0097729),70
90S Preribosome (GO:0030686),12
AMPA Glutamate Receptor Complex (GO:0032281),19
AP-1 Adaptor Complex (GO:0030121),11
AP-2 Adaptor Complex (GO:0030122),8
AP-3 Adaptor Complex (GO:0030123),6
ATAC Complex (GO:0140672),13
ATP-binding Cassette (ABC) Transporter Complex (GO:0043190),5

==> GO_Molecular_Function_2013_counts.csv <==
Pathway,Count
chaperone binding (GO:0051087),16
S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),32
unfolded protein binding (GO:0051082),59
hormone binding (GO:0042562),19
NF-kappaB binding (GO:0051059),14
"transferase activity, transferring glycosyl groups (GO:0016757)",124
"transferase activity, transferring acyl groups (GO:0016746)",95
metal ion binding (GO:0046872),400
transferase activity (GO:0016740),831

==> GO_Molecular_Function_2015_counts.csv <==
Pathway,Count
serine-type endopeptidase activity (GO:0004252),167
peptidoglycan binding (GO:0042834),11
lipoprotein particle receptor activity (GO:0030228),14
extracellular matrix binding (GO:0050840),51
nucleoside-triphosphatase regulator activity (GO:0060589),330
protein-cysteine S-palmitoyltransferase activity (GO:0019706),25
NAD-dependent histone deacetylase activity (H4-K16 specific) (GO:0046970),12
lysozyme activity (GO:0003796),10
glutamate receptor activity (GO:0008066),27

==> GO_Molecular_Function_2017b_counts.csv <==
Pathway,Count
phospholipase A2 activity (GO:0004623),52
CCR9 chemokine receptor binding (GO:0031734),21
D-glucose transmembrane transporter activity (GO:0055056),14
8-oxo-GDP phosphatase activity (GO:0044716),8
methylene-fatty-acyl-phospholipid synthase activity (GO:0004481),13
voltage-gated proton channel activity (GO:0030171),6
MAP kinase activity involved in innate immune response (GO:0038075),11
"3',5'-cyclic-GMP phosphodiesterase activity (GO:0047555)",14
acyl-CoA hydrolase activity (GO:0047617),15

==> GO_Molecular_Function_2017_counts.csv <==
Pathway,Count
serine-type endopeptidase activity (GO:0004252),185
immunoglobulin receptor binding (GO:0034987),46
GTPase activator activity (GO:0005096),224
Rab GTPase binding (GO:0017137),118
ubiquinol-cytochrome-c reductase activity (GO:0008121),8
potassium:chloride symporter activity (GO:0015379),6
potassium ion symporter activity (GO:0022820),6
RNA binding (GO:0003723),1194
ubiquitin protein ligase activity (GO:0061630),143

==> GO_Molecular_Function_2018_counts.csv <==
Pathway,Count
semaphorin receptor activity (GO:0017154),11
7SK snRNA binding (GO:0097322),6
androgen receptor binding (GO:0050681),42
transcription regulatory region DNA binding (GO:0044212),374
protein phosphatase inhibitor activity (GO:0004864),23
transmembrane receptor protein serine/threonine kinase activity (GO:0004675),14
RNA 7-methylguanosine cap binding (GO:0000340),9
Lys48-specific deubiquitinase activity (GO:1990380),10
protein serine/threonine kinase activity (GO:0004674),368

==> GO_Molecular_Function_2021_counts.csv <==
Pathway,Count
"1,4-alpha-oligoglucan phosphorylase activity (GO:0004645)",5
1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),13
1-acylglycerophosphocholine O-acyltransferase activity (GO:0047184),6
1-alkyl-2-acetylglycerophosphocholine esterase activity (GO:0003847),7
1-phosphatidylinositol binding (GO:0005545),15
1-phosphatidylinositol-3-kinase activity (GO:0016303),10
1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),16
1-phosphatidylinositol-4-phosphate 3-kinase activity (GO:0035005),7
1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0016308),6

==> GO_Molecular_Function_2023_counts.csv <==
Pathway,Count
1-Acylglycerol-3-Phosphate O-acyltransferase Activity (GO:0003841),19
1-Acylglycerophosphocholine O-acyltransferase Activity (GO:0047184),5
1-Alkyl-2-Acetylglycerophosphocholine Esterase Activity (GO:0003847),6
1-Phosphatidylinositol Binding (GO:0005545),14
1-Phosphatidylinositol-3-Kinase Activity (GO:0016303),9
1-Phosphatidylinositol-3-Kinase Regulator Activity (GO:0046935),14
1-Phosphatidylinositol-4-Phosphate 3-Kinase Activity (GO:0035005),6
1-Phosphatidylinositol-4-Phosphate 5-Kinase Activity (GO:0016308),6
11-Cis Retinal Binding (GO:0005502),5

==> GTEx_Aging_Signatures_2021_counts.csv <==
Pathway,Count
GTEx Uterus 20-29 vs 40-49 Up,250
GTEx Uterus 20-29 vs 40-49 Down,250
GTEx Thyroid 20-29 vs 40-49 Up,250
GTEx Thyroid 20-29 vs 40-49 Down,250
GTEx Kidney 20-29 vs 50-59 Up,250
GTEx Kidney 20-29 vs 50-59 Down,250
GTEx SalivaryGland 20-29 vs 40-49 Up,250
GTEx SalivaryGland 20-29 vs 40-49 Down,250
GTEx Vagina 20-29 vs 70-79 Up,250

==> GTEx_Tissue_Expression_Down_counts.csv <==
Pathway,Count
GTEX-S341-0006-SM-3NM8D blood female 40-49 years,10684
GTEX-WH7G-0005-SM-3NMBX blood male 40-49 years,10653
GTEX-WFON-0005-SM-3NMC9 blood male 40-49 years,10082
GTEX-X5EB-0006-SM-46MV5 blood male 40-49 years,10913
GTEX-PWCY-0005-SM-33HBP blood female 20-29 years,10487
GTEX-P4PP-0005-SM-2HMKX blood female 30-39 years,10330
GTEX-R55G-0006-SM-2TC6O blood female 40-49 years,10699
GTEX-XPVG-0006-SM-4B65Z blood male 50-59 years,10235
GTEX-XUZC-0005-SM-4BOQ8 blood female 30-39 years,9061

==> GTEx_Tissue_Expression_Up_counts.csv <==
Pathway,Count
GTEX-S341-0006-SM-3NM8D blood female 40-49 years,1002
GTEX-WH7G-0005-SM-3NMBX blood male 40-49 years,844
GTEX-WFON-0005-SM-3NMC9 blood male 40-49 years,1040
GTEX-X5EB-0006-SM-46MV5 blood male 40-49 years,820
GTEX-PWCY-0005-SM-33HBP blood female 20-29 years,1062
GTEX-P4PP-0005-SM-2HMKX blood female 30-39 years,1149
GTEX-R55G-0006-SM-2TC6O blood female 40-49 years,830
GTEX-XPVG-0006-SM-4B65Z blood male 50-59 years,611
GTEX-XUZC-0005-SM-4BOQ8 blood female 30-39 years,1227

==> GTEx_Tissues_V8_2023_counts.csv <==
Pathway,Count
Adipose - Subcutaneous Female 60-69 Up,100
Muscle - Skeletal Female 60-69 Up,100
Artery - Tibial Female 60-69 Up,100
Artery - Coronary Female 60-69 Up,82
Heart - Atrial Appendage Female 60-69 Up,100
Adipose - Visceral (Omentum) Female 60-69 Up,41
Uterus Female 60-69 Up,100
Vagina Female 60-69 Up,55
Breast - Mammary Tissue Female 60-69 Up,44

==> GWAS_Catalog_2019_counts.csv <==
Pathway,Count
Beta2-Glycoprotein I plasma levels,8
"1,5-anhydroglucitol levels",9
AIDS progression,16
Abdominal aortic aneurysm,20
Ability to confide in someone,22
Accelerated cognitive decline after conversion of MCI to Alzheimer's disease,10
Accelerometer-based physical activity measurement (average acceleration),6
Acne (severe),223
Activated partial thromboplastin time,36

==> GWAS_Catalog_2023_counts.csv <==
Pathway,Count
BMI (Adjusted For Smoking Behaviour),54
Body Mass Index (Joint Analysis Main Effects And Smoking Interaction),53
Height,6159
Itch Intensity From Mosquito Bite Adjusted By Bite Size,127
Low Density Lipoprotein Cholesterol Levels,754
Mosquito Bite Size,97
Waist-to-hip Ratio Adjusted For BMI (Joint Analysis For Main Effect And Physical Activity Interaction),29
Barrett's Esophagus,13
Esophageal Adenocarcinoma,10

==> HDSigDB_Human_2021_counts.csv <==
Pathway,Count
ABeta-induced Microglial Genes PMID14612454,518
AD Changed Genes In Choroid Plexus GSE110226,2053
AD Down-Regulated Genes In Choroid Plexus GSE110226,829
AD Up-Regulated Genes In Choroid Plexus GSE110226,1231
AR-ATXN3 Shared Co-Expressed Genes In HD-associated Brain Region PMID29249939,6
ATN1-ATXN2 Shared Co-Expressed Genes In HD-associated Brain Region PMID29249939,473
ATN1-HTT Shared Co-Expressed Genes In HD-associated Brain Region PMID29249939,62
Activity-dependent Synaptic AMPA Receptor Removal CHDI115,89
Aged Astrocyte-Enriched Genes In Mouse Cortex PMID23954174,356

==> HDSigDB_Mouse_2021_counts.csv <==
Pathway,Count
ABeta-induced Microglial Genes PMID14612454,492
AD Changed Genes In Choroid Plexus GSE110226,2032
AD Down-Regulated Genes In Choroid Plexus GSE110226,808
AD Up-Regulated Genes In Choroid Plexus GSE110226,1232
AR-ATXN3 Shared Co-Expressed Genes In HD-associated Brain Region PMID29249939,5
ATN1-ATXN2 Shared Co-Expressed Genes In HD-associated Brain Region PMID29249939,456
ATN1-HTT Shared Co-Expressed Genes In HD-associated Brain Region PMID29249939,63
Activity-dependent Synaptic AMPA Receptor Removal CHDI115,92
Aged Astrocyte-Enriched Genes In Mouse Cortex PMID23954174,416

==> HMDB_Metabolites_counts.csv <==
Pathway,Count
2-Ketobutyric acid (HMDB00005),18
2-Methoxyestrone (HMDB00010),19
Sulfatide (HMDB00024),11
Tetrahydrobiopterin (HMDB00027),14
Biotin (HMDB00030),11
Androsterone (HMDB00031),25
Aldosterone (HMDB00037),15
Butyric acid (HMDB00039),11
Acetic acid (HMDB00042),29

==> HMS_LINCS_KinomeScan_counts.csv <==
Pathway,Count
MRT67307,172
Sorafenib,106
WZ4003,92
AZ-628,72
Motesanib,6
Torin1,83
KIN001-111,121
Dabrafenib,195
CGP60474,20

==> HomoloGene_counts.csv <==
Pathway,Count
H.sapiens: The human species,172
"Homininae: Hominids including including gorillas, chimpanzees",560
Catarrhini: Higher primates,498
Euarchontoglires: Superorder of Mammals including rodents and primates,285
Boreoeutheria: Placental Mammals,2907
Amniota: Four limbed vertebrates that can lay eggs on land,633
Tetrapoda: First four limbed Vertebrates and Descendents,1483
Euteleostomi: Bony vertebrates,6637
Arthropoda: Insects,1439

==> HuBMAP_ASCTplusB_augmented_2022_counts.csv <==
Pathway,Count
Paneth Cell Of Epithelium Proper Of Small intestine - Small Intestine,102
Duodenal Goblet cell - Small Intestine,102
Tuft cell - Small Intestine,103
absorptive - Small Intestine,102
enterocyte - Small Intestine,104
Endocrine Lineage cell - Small Intestine,101
Stem cell - Small Intestine,105
endothelial - Small Intestine,103
myofibroblast - Small Intestine,102

==> HuBMAP_ASCT_plus_B_augmented_w_RNAseq_Coexpression_counts.csv <==
Pathway,Count
Absorptive (id:32),85
Abt Entry (id:33),108
Activated Dc (id:34),123
Adipocyte (id:35),100
Afferent Arteriole Endothelial Cell (id:39),102
Airway Smooth Muscle (id:41),99
Alveolar Macrophage (id:42),100
Arterial Endothelial Cell (id:45),101
Arteriole Endothelial Cell (id:46),100

==> HumanCyc_2015_counts.csv <==
Pathway,Count
&gamma;-glutamyl cycle,7
&gamma;-linolenate biosynthesis,14
1D-myo-inositol hexakisphosphate biosynthesis II (mammalian),15
2'-deoxy-&alpha;-D-ribose 1-phosphate degradation,6
2-oxobutanoate degradation,8
3-phosphoinositide biosynthesis,27
3-phosphoinositide degradation,20
4-hydroxy-2-nonenal detoxification,5
BMP Signalling Pathway,8

==> HumanCyc_2016_counts.csv <==
Pathway,Count
creatine-phosphate biosynthesis Homo sapiens PWY-6158,5
mitochondrial L-carnitine shuttle Homo sapiens PWY-6111,5
pyridoxal 5'-phosphate salvage Homo sapiens PLPSAL-PWY,5
protein ubiquitylation Homo sapiens PWY-7511,44
protein citrullination Homo sapiens PWY-4921,5
inositol pyrophosphates biosynthesis Homo sapiens PWY-6369,7
1D-myo-inositol hexakisphosphate biosynthesis II (mammalian) Homo sapiens PWY-6362,15
"D-myo-inositol (1,3,4)-trisphosphate biosynthesis Homo sapiens PWY-6364",15
"superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism Homo sapiens PWY-6358",20

==> Human_Gene_Atlas_counts.csv <==
Pathway,Count
Thyroid,388
CD33+ Myeloid,679
Testis,384
Salivarygland,57
CD14+ Monocytes,383
TestisLeydigCell,107
Ovary,41
CD8+ Tcells,602
Tonsil,26

==> Human_Phenotype_Ontology_counts.csv <==
Pathway,Count
Abnormality of B cell number (HP:0010975),9
B lymphocytopenia (HP:0010976),8
Hypobetalipoproteinemia (HP:0003563),8
Gastrointestinal atresia (HP:0002589),17
Birth length less than 3rd percentile (HP:0003561),8
Peritonitis (HP:0002586),8
Abnormality of the peritoneum (HP:0002585),17
Colitis (HP:0002583),12
Volvulus (HP:0002580),8

==> huMAP_counts.csv <==
Pathway,Count
NOL12,47
SND1,11
RPL8,98
COMMD1,8
PDS5B,9
TPR,48
GNAI2,5
LMNB1,14
RPL5,137

==> IDG_Drug_Targets_2022_counts.csv <==
Pathway,Count
Levobupivacaine,8
(S)-nitrendipine,5
Acamprosate,10
Acarbose,5
Paracetamol,16
Acetazolamide,14
Acetoxolone,6
Acetylcholine,12
Acetylcysteine,5

==> InterPro_Domains_2019_counts.csv <==
Pathway,Count
14-3-3 domain,7
"2-5-oligoadenylate synthetase, N-terminal",5
2Fe-2S ferredoxin-type iron-sulfur binding domain,6
3'-5' exonuclease domain,5
"3'5'-cyclic nucleotide phosphodiesterase, catalytic domain",21
3-beta hydroxysteroid dehydrogenase/isomerase,6
"3-oxo-5-alpha-steroid 4-dehydrogenase, C-terminal",5
"4Fe-4S ferredoxin-type, iron-sulphur binding domain",5
AAA+ ATPase domain,135

==> Jensen_COMPARTMENTS_counts.csv <==
Pathway,Count
Sperm head plasma membrane,12
Sperm individualization complex,11
Sperm plasma membrane,121
Sphere organelle,8
Spindle envelope,6
Spindle matrix,18
Spindle pole body,190
Spine apparatus,107
Spore wall,94

==> Jensen_DISEASES_counts.csv <==
Pathway,Count
3-M syndrome,14
3-Methylcrotonyl-CoA carboxylase deficiency,10
3-methylglutaconic aciduria,28
3p- syndrome,18
46 XY gonadal dysgenesis,8
ADULT syndrome,8
AGAT deficiency,5
ARC syndrome,12
Aarskog-Scott syndrome,11

==> Jensen_TISSUES_counts.csv <==
Pathway,Count
Adipose tissue,12174
Adrenal cortex,4574
Adrenal gland,16140
Amygdala,5279
Ascites,884
B-lymphoblastoid cell,5983
B-lymphocyte,8270
BTO:0004410,9290
BTO:0005453,7164

==> KEA_2013_counts.csv <==
Pathway,Count
STK19,6
RYK,4
BUB1B,14
STK10,5
STK11,32
STK16,8
HIPK3,26
HIPK2,43
HIPK1,8

==> KEA_2015_counts.csv <==
Pathway,Count
FGFR3,7
MAPKAPK2,47
ABL2,14
CSNK1G2,12
AKT1,210
EIF2AK4,1
DAPK1,9
ITK,13
RAF1,6

==> KEGG_2013_counts.csv <==
Pathway,Count
HSA00010 GLYCOLYSIS AND GLUCONEOGENESIS,64
HSA00020 CITRATE CYCLE,29
HSA00030 PENTOSE PHOSPHATE PATHWAY,26
HSA00031 INOSITOL METABOLISM,2
HSA00040 PENTOSE AND GLUCURONATE INTERCONVERSIONS,25
HSA00051 FRUCTOSE AND MANNOSE METABOLISM,42
HSA00052 GALACTOSE METABOLISM,32
HSA00053 ASCORBATE AND ALDARATE METABOLISM,9
HSA00061 FATTY ACID BIOSYNTHESIS,6

==> KEGG_2015_counts.csv <==
Pathway,Count
1 and 2 methylnaphthalene degradation,20
3 chloroacrylic acid degradation,15
abc transporters general,44
acute myeloid leukemia,52
adherens junction,75
adipocytokine signaling pathway,71
alanine and aspartate metabolism,33
alkaloid biosynthesis i,5
alkaloid biosynthesis ii,14

==> KEGG_2016_counts.csv <==
Pathway,Count
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate Homo sapiens hsa00532,20
Glycosaminoglycan biosynthesis - heparan sulfate / heparin Homo sapiens hsa00534,24
Glycosylphosphatidylinositol(GPI)-anchor biosynthesis Homo sapiens hsa00563,25
Steroid biosynthesis Homo sapiens hsa00100,20
SNARE interactions in vesicular transport Homo sapiens hsa04130,34
Protein export Homo sapiens hsa03060,23
Protein processing in endoplasmic reticulum Homo sapiens hsa04141,169
N-Glycan biosynthesis Homo sapiens hsa00510,49
Other types of O-glycan biosynthesis Homo sapiens hsa00514,31

==> KEGG_2019_Human_counts.csv <==
Pathway,Count
ABC transporters,45
AGE-RAGE signaling pathway in diabetic complications,100
AMPK signaling pathway,120
Acute myeloid leukemia,66
Adherens junction,72
Adipocytokine signaling pathway,69
Adrenergic signaling in cardiomyocytes,145
African trypanosomiasis,37
"Alanine, aspartate and glutamate metabolism",35

==> KEGG_2019_Mouse_counts.csv <==
Pathway,Count
ABC transporters,48
AGE-RAGE signaling pathway in diabetic complications,101
AMPK signaling pathway,126
Acute myeloid leukemia,69
Adherens junction,72
Adipocytokine signaling pathway,71
Adrenergic signaling in cardiomyocytes,148
African trypanosomiasis,39
"Alanine, aspartate and glutamate metabolism",37

==> KEGG_2021_Human_counts.csv <==
Pathway,Count
ABC transporters,45
AGE-RAGE signaling pathway in diabetic complications,100
AMPK signaling pathway,120
Acute myeloid leukemia,67
Adherens junction,71
Adipocytokine signaling pathway,69
Adrenergic signaling in cardiomyocytes,150
African trypanosomiasis,37
"Alanine, aspartate and glutamate metabolism",37

==> KEGG_2021_Mouse_counts.csv <==
Pathway,Count
ABC transporters,50
AGE-RAGE signaling pathway in diabetic complications,101
AMPK signaling pathway,126
Acute myeloid leukemia,70
Adherens junction,71
Adipocytokine signaling pathway,71
Adrenergic signaling in cardiomyocytes,152
African trypanosomiasis,39
"Alanine, aspartate and glutamate metabolism",39

==> Kinase_Perturbations_from_GEO_down_counts.csv <==
Pathway,Count
BRAF druginhibition 175 GSE42872,300
BRAF druginhibition 38 GDS5085,300
FGFR3 druginhibition 36 GDS5023,300
ERBB3 knockdown 65 GSE19921,300
BRAF knockdown 193 GSE5481,300
AURKA druginhibition 196 GSE57810,300
HUNK knockout 240 GSE14226,300
TGFBR2 knockout 293 GSE46211,300
TGFBR2 knockout 292 GSE46150,300

==> Kinase_Perturbations_from_GEO_up_counts.csv <==
Pathway,Count
BRAF druginhibition 175 GSE42872,300
BRAF druginhibition 38 GDS5085,300
FGFR3 druginhibition 36 GDS5023,300
ERBB3 knockdown 65 GSE19921,300
BRAF knockdown 193 GSE5481,300
AURKA druginhibition 196 GSE57810,300
HUNK knockout 240 GSE14226,300
TGFBR2 knockout 293 GSE46211,300
TGFBR2 knockout 292 GSE46150,300

==> KOMP2_Mouse_Phenotypes_2022_counts.csv <==
Pathway,Count
Increased Lean Body Mass (MP:0003960),284
Decreased Erythrocyte Cell Number (MP:0002875),170
Embryonic Lethality Prior To Organogenesis (MP:0013292),510
Abnormal Uterus Morphology (MP:0001120),162
Abnormal Bone Structure (MP:0003795),222
Decreased Circulating Glucose Level (MP:0005560),204
Abnormal Auditory Brainstem Response (MP:0004738),309
Embryonic Lethality Prior To Tooth Bud Stage (MP:0013293),311
Enlarged Spleen (MP:0000691),360

==> L1000_Kinase_and_GPCR_Perturbations_down_counts.csv <==
Pathway,Count
ABCF1 knockdown 96h A375,300
ABL1 knockdown 96h A375,300
ABL2 knockdown 96h A375,300
ACVR1 knockdown 96h A375,300
ADCK3 knockdown 96h A375,300
ADORA2A knockdown 96h A375,300
ADORA2B knockdown 96h A375,300
ADRA2A knockdown 96h A375,300
ADRA2C knockdown 96h A375,300

==> L1000_Kinase_and_GPCR_Perturbations_up_counts.csv <==
Pathway,Count
ABCF1 knockdown 96h A375,300
ABL1 knockdown 96h A375,300
ABL2 knockdown 96h A375,300
ACVR1 knockdown 96h A375,300
ADCK3 knockdown 96h A375,300
ADORA2A knockdown 96h A375,300
ADORA2B knockdown 96h A375,300
ADRA2A knockdown 96h A375,300
ADRA2C knockdown 96h A375,300

==> Ligand_Perturbations_from_GEO_down_counts.csv <==
Pathway,Count
estradiol mouse uterus GSE23072 ligand:77,419
Interleukin-1 beta mouse embryonic fibroblasts from IRAK-4 kinase deficient mutants GDS2641 ligand:59,331
interleukin-12 mouse CD8 T cells GSE72791 ligand:236,432
17beta-estradiol mouse uterus GDS1058 ligand:37,237
Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242,276
interleukin 28B human hepatocyte GDS4390 ligand:183,271
interleukin 28B human hepatocyte GDS4390 ligand:189,201
TGF-beta human Panc-1 cells GDS4106 ligand:16,286
estradiol human MCF-7 cells GDS4052 ligand:268,242

==> Ligand_Perturbations_from_GEO_up_counts.csv <==
Pathway,Count
estradiol mouse uterus GSE23072 ligand:77,181
Interleukin-1 beta mouse embryonic fibroblasts from IRAK-4 kinase deficient mutants GDS2641 ligand:59,269
interleukin-12 mouse CD8 T cells GSE72791 ligand:236,168
17beta-estradiol mouse uterus GDS1058 ligand:37,363
Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242,324
interleukin 28B human hepatocyte GDS4390 ligand:183,329
interleukin 28B human hepatocyte GDS4390 ligand:189,399
TGF-beta human Panc-1 cells GDS4106 ligand:16,314
estradiol human MCF-7 cells GDS4052 ligand:268,358

==> LINCS_L1000_Chem_Pert_Consensus_Sigs_counts.csv <==
Pathway,Count
Afatinib Up,237
Erlotinib Up,231
Neratinib Up,232
Lapatinib Up,244
Pazopanib Up,240
HMN-214 Up,240
Fulvestrant Up,245
Vorinostat Up,246
Mitoxantrone Up,243

==> LINCS_L1000_Chem_Pert_down_counts.csv <==
Pathway,Count
CPC001 HA1E 24H-hemado-10.0,46
CPC001 HA1E 24H-ici-89406-10.0,56
CPC001 HA1E 24H-n-benzylnaltrindole hydrochloride-10.0,101
CPC001 HA1E 24H-cilnidipine-10.0,50
CPC001 HA1E 24H-norketamine hydrochloride-10.0,53
CPC001 HA1E 24H-sdz 21009-10.0,13
CPC001 HA1E 24H-brefeldin a-10.0,211
CPC001 HA1E 24H-trichostatin a-10.0,200
CPC001 HA1E 24H-geldanamycin-10.0,166

==> LINCS_L1000_Chem_Pert_up_counts.csv <==
Pathway,Count
CPC001 HA1E 24H-hemado-10.0,74
CPC001 HA1E 24H-ici-89406-10.0,40
CPC001 HA1E 24H-n-benzylnaltrindole hydrochloride-10.0,110
CPC001 HA1E 24H-cilnidipine-10.0,11
CPC001 HA1E 24H-norketamine hydrochloride-10.0,72
CPC001 HA1E 24H-sdz 21009-10.0,60
CPC001 HA1E 24H-brefeldin a-10.0,102
CPC001 HA1E 24H-trichostatin a-10.0,198
CPC001 HA1E 24H-geldanamycin-10.0,122

==> LINCS_L1000_CRISPR_KO_Consensus_Sigs_counts.csv <==
Pathway,Count
A1BG Up,243
A1CF Up,245
A2M Up,242
AADACL2 Up,243
AADAT Up,239
AAK1 Up,242
AAMP Up,241
AASS Up,246
AATK Up,244

==> LINCS_L1000_Ligand_Perturbations_down_counts.csv <==
Pathway,Count
SCF-SKBR3,162
TNFA-SKBR3,159
MSP-SKBR3,163
IFNA-SKBR3,159
PDGFBB-SKBR3,156
EPR-SKBR3,172
IL1-MCF10A,159
EPG-SKBR3,148
EGF-SKBR3,157

==> LINCS_L1000_Ligand_Perturbations_up_counts.csv <==
Pathway,Count
SCF-SKBR3,159
TNFA-SKBR3,153
MSP-SKBR3,158
IFNA-SKBR3,138
PDGFBB-SKBR3,155
EPR-SKBR3,156
IL1-MCF10A,146
EPG-SKBR3,162
EGF-SKBR3,153

==> lncHUB_lncRNA_Co-Expression_counts.csv <==
Pathway,Count
LINC01587,100
LINC00544,100
LINC00029,100
LINC00470,100
LINC01558,100
LINC00525,100
LINC00266-1,100
LINC00467,100
LINC01931,100

==> MAGMA_Drugs_and_Diseases_counts.csv <==
Pathway,Count
African Trypanosomiasis,40
Burkitts Lymphoma,10
Crohns Disease,12
Cushings Syndrome,7
Ewings Sarcoma,17
Graves Disease,17
Hodgkins Lymphoma,11
Kaposi Sarcoma,35
Parkinsons Disease,16

==> MAGNET_2023_counts.csv <==
Pathway,Count
Healthy Kupffer Cells 1 Seidman Et Al. 2020,522
Ly6c Hi And Lo Recruited Macrophages 2 Seidman Et Al. 2020,791
Ly6c Hi Recruited Macrophages 3 Seidman Et Al. 2020,250
NASH Kupffer Cells 4 Seidman Et Al. 2020,277
CCR2+IL1B+ Infiltrating Macrophages 1 Culemann Et Al. 2019,355
CX3CR1+ Lining Macrophages 2 Culemann Et Al. 2019,296
RETNLA+ Interstitial Macrophages 3 Culemann Et Al. 2019,251
MHCII+ Interstitial Macrophages 4 Culemann Et Al. 2019,65
CCR2+ARG1+ Infiltrating Macrophages 5 Culemann Et Al. 2019,304

==> MCF7_Perturbations_from_GEO_down_counts.csv <==
Pathway,Count
v-Myb GSE2815 mcf7:76,148
trans-retinoic acid + hydrocorti GSE32161 mcf7:20,276
CDH11 siRNA 96 hrs GSE53668 mcf7:297,296
RON and MSP overexpression GSE52567 mcf7:480,347
cisplatin GSE28274 mcf7:48,346
transfection with siRNA targeting metastasis suppressor ARGHDIB GSE53668 mcf7:259,173
transfection with siRNA targeting metastasis suppressor ARGHDIB GSE53668 mcf7:258,140
cysteine GSE62673 mcf7:167,300
"ICI-182,780(Fulvestrant) GSE35428 mcf7:338",438

==> MCF7_Perturbations_from_GEO_up_counts.csv <==
Pathway,Count
v-Myb GSE2815 mcf7:76,452
trans-retinoic acid + hydrocorti GSE32161 mcf7:20,324
CDH11 siRNA 96 hrs GSE53668 mcf7:297,304
RON and MSP overexpression GSE52567 mcf7:480,253
cisplatin GSE28274 mcf7:48,254
transfection with siRNA targeting metastasis suppressor ARGHDIB GSE53668 mcf7:259,427
transfection with siRNA targeting metastasis suppressor ARGHDIB GSE53668 mcf7:258,460
cysteine GSE62673 mcf7:167,300
"ICI-182,780(Fulvestrant) GSE35428 mcf7:338",162

==> Metabolomics_Workbench_Metabolites_2022_counts.csv <==
Pathway,Count
(S)-Methylmalonate Semialdehyde,10
"1,2-Diacyl-sn-glycerol",39
1-(1-Alkenyl)-sn-glycero-3-phosphoethanolamine,17
1-Acyl-sn-glycero-3-phosphocholine,23
1-Acyl-sn-glycero-3-phosphoethanolamine,21
1-Acyl-sn-glycerol 3-Phosphate,10
1-Acylglycerol,5
1-Organyl-2-lyso-sn-glycero-3-phosphocholine,21
1-Phosphatidyl-D-myo-inositol,35

==> MGI_Mammalian_Phenotype_2013_counts.csv <==
Pathway,Count
MP0008438 abnormal cutaneous collagen ,17
MP0002909 abnormal adrenal gland ,25
MP0000609 abnormal liver physiology ,442
MP0001730 embryonic growth arrest ,222
MP0001731 abnormal postnatal growth ,733
MP0002210 abnormal sex determination ,426
MP0000604 amyloidosis ,42
MP0000598 abnormal liver morphology ,586
MP0005334 abnormal fat pad ,235

==> MGI_Mammalian_Phenotype_2017_counts.csv <==
Pathway,Count
MP:0000003 abnormal adipose tissue morphology,16
MP:0000005 increased brown adipose tissue amount,30
MP:0000008 increased white adipose tissue amount,32
MP:0000010 abnormal abdominal fat pad morphology,18
MP:0000013 abnormal adipose tissue distribution,12
MP:0000015 abnormal ear pigmentation,8
MP:0000017 big ears,4
MP:0000018 small ears,19
MP:0000022 abnormal ear shape,5

==> MGI_Mammalian_Phenotype_Level_3_counts.csv <==
Pathway,Count
MP0001919 abnormal reproductive system ,1240
MP0000685 abnormal immune system ,1575
MP0010680 abnormal skin adnexa ,129
MP0000516 abnormal urinary system ,629
MP0002139 abnormal hepatobiliary system ,469
MP0002138 abnormal hepatobiliary system ,619
MP0002133 abnormal respiratory system ,622
MP0002132 abnormal respiratory system ,529
MP0000358 abnormal cell content/ ,275

==> MGI_Mammalian_Phenotype_Level_4_2019_counts.csv <==
Pathway,Count
MP:0000600 liver hypoplasia,59
MP:0001716 abnormal placenta labyrinth morphology,85
MP:0001698 decreased embryo size,537
MP:0001092 abnormal trigeminal ganglion morphology,36
MP:0000961 abnormal dorsal root ganglion morphology,64
MP:0000245 abnormal erythropoiesis,117
MP:0000828 abnormal fourth ventricle morphology,14
MP:0000826 abnormal third ventricle morphology,19
MP:0005039 hypoxia,29

==> MGI_Mammalian_Phenotype_Level_4_2021_counts.csv <==
Pathway,Count
abdominal situs ambiguus MP:0011250,10
abdominal situs inversus MP:0011249,8
aberrant origin of the right subclavian artery MP:0010465,12
abnormal abdominal fat pad morphology MP:0000010,20
abnormal abdominal wall morphology MP:0003257,12
abnormal acrosome morphology MP:0008898,28
abnormal actin cytoskeleton morphology MP:0020849,11
abnormal action potential MP:0005402,88
abnormal active avoidance behavior MP:0002798,9

==> MGI_Mammalian_Phenotype_Level_4_counts.csv <==
Pathway,Count
MP0008438 abnormal cutaneous collagen ,16
MP0002909 abnormal adrenal gland ,24
MP0000609 abnormal liver physiology ,441
MP0001730 embryonic growth arrest ,221
MP0001731 abnormal postnatal growth ,732
MP0002210 abnormal sex determination ,425
MP0000604 amyloidosis ,41
MP0000598 abnormal liver morphology ,585
MP0005334 abnormal fat pad ,234

==> Microbe_Perturbations_from_GEO_down_counts.csv <==
Pathway,Count
"Influenza A mouse blood, 1 day post-infection GSE57384 microbe:299",276
Hepatitis C virus human CD4+ T-lymphocytes GDS4880 microbe:118,224
Aeromonas caviae mouse small intestine (neonatal) GDS2552 microbe:166,297
Trypanosoma cruzi mouse skin GSE13522 microbe:247,390
gammaherpesvirus 68 (MHV-68) mouse spleen GDS4775 microbe:111,329
Trypanosoma cruzi mouse skin GSE13522 microbe:249,285
Leishmania braziliensis human skin GSE55664 microbe:256,300
Leishmania braziliensis human skin GSE55664 microbe:257,300
Yersinia enterocolitica mouse bone marrow-derived macrophages GDS1465 microbe:34,293

==> Microbe_Perturbations_from_GEO_up_counts.csv <==
Pathway,Count
"Influenza A mouse blood, 1 day post-infection GSE57384 microbe:299",324
Hepatitis C virus human CD4+ T-lymphocytes GDS4880 microbe:118,376
Aeromonas caviae mouse small intestine (neonatal) GDS2552 microbe:166,303
Trypanosoma cruzi mouse skin GSE13522 microbe:247,210
gammaherpesvirus 68 (MHV-68) mouse spleen GDS4775 microbe:111,271
Trypanosoma cruzi mouse skin GSE13522 microbe:249,315
Leishmania braziliensis human skin GSE55664 microbe:256,300
Leishmania braziliensis human skin GSE55664 microbe:257,300
Yersinia enterocolitica mouse bone marrow-derived macrophages GDS1465 microbe:34,307

==> miRTarBase_2017_counts.csv <==
Pathway,Count
hsa-miR-507,187
hsa-miR-6723-5p,16
hsa-miR-3934-3p,93
hsa-miR-4657,73
hsa-miR-130b-5p,342
hsa-miR-6782-5p,95
hsa-miR-190b,62
hsa-miR-1286,103
hsa-miR-126-3p,58

==> MSigDB_Computational_counts.csv <==
Pathway,Count
MORF ATRX,211
MORF ATOX1,80
MORF BCL2,222
MORF BNIP1,190
MORF BAG5,57
MORF BCL2L11,188
MORF BECN1,101
MORF BRCA1,264
MORF BUB1,52

==> MSigDB_Hallmark_2020_counts.csv <==
Pathway,Count
TNF-alpha Signaling via NF-kB,200
Hypoxia,200
Cholesterol Homeostasis,74
Mitotic Spindle,199
Wnt-beta Catenin Signaling,42
TGF-beta Signaling,54
IL-6/JAK/STAT3 Signaling,87
DNA Repair,150
G2-M Checkpoint,200

==> MSigDB_Oncogenic_Signatures_counts.csv <==
Pathway,Count
GLI1 UP.V1 DN,29
GLI1 UP.V1 UP,27
E2F1 UP.V1 DN,193
E2F1 UP.V1 UP,189
EGFR UP.V1 DN,196
EGFR UP.V1 UP,193
ERB2 UP.V1 DN,197
ERB2 UP.V1 UP,191
GCNP SHH UP EARLY.V1 DN,169

==> NCI-60_Cancer_Cell_Lines_counts.csv <==
Pathway,Count
MCF7,397
T3M4,290
U20S,458
HSG,276
HL60,1914
U118,144
GM1600,407
GM2313,301
PANC1,337

==> NCI-Nature_2015_counts.csv <==
Pathway,Count
ALK1 signaling events,25
ALK2 signaling events,11
AP-1 transcription factor network,69
ATF-2 transcription factor network,58
ATM pathway,34
ATR signaling pathway,39
Alpha-synuclein signaling,32
Alpha4 beta1 integrin signaling events,32
Alpha6 beta4 integrin-ligand interactions,11

==> NCI-Nature_2016_counts.csv <==
Pathway,Count
Effects of Botulinum toxin Homo sapiens d236ff84-6191-11e5-8ac5-06603eb7f303,9
Glypican 3 network Homo sapiens 07762c7e-6193-11e5-8ac5-06603eb7f303,8
Rapid glucocorticoid signaling Homo sapiens 01db03fd-6195-11e5-8ac5-06603eb7f303,8
CD40/CD40L signaling Homo sapiens 1971792f-6190-11e5-8ac5-06603eb7f303,30
p38 MAPK signaling pathway Homo sapiens 99bea41b-6194-11e5-8ac5-06603eb7f303,27
TNF receptor signaling pathway Homo sapiens 316be05e-6196-11e5-8ac5-06603eb7f303,46
Ceramide signaling pathway Homo sapiens d3747df2-6190-11e5-8ac5-06603eb7f303,44
Caspase Cascade in Apoptosis Homo sapiens b9d3ef2e-618f-11e5-8ac5-06603eb7f303,55
HIV-1 Nef: Negative effector of Fas and TNF-alpha Homo sapiens 41a75463-6193-11e5-8ac5-06603eb7f303,35

==> NIH_Funded_PIs_2017_AutoRIF_ARCHS4_Predictions_counts.csv <==
Pathway,Count
Aakalu Vinay (University Of Illinois At Chicago),200
Aarons Gregory (University Of California San Diego),200
Aaronson Stuart A (Icahn School Of Medicine At Mount Sinai),200
Abaci Hasan Erbil (Columbia University Health Sciences),200
Abadir Peter M (Johns Hopkins University),200
Abais-Battad Justine M (Medical College Of Wisconsin),200
Aballay Alejandro (Duke University),200
Abate-Shen Cory (Columbia University Health Sciences),200
Abbate Antonio (Virginia Commonwealth University),200

==> NIH_Funded_PIs_2017_GeneRIF_ARCHS4_Predictions_counts.csv <==
Pathway,Count
Aaronson Stuart A (Icahn School Of Medicine At Mount Sinai),200
Abate-Shen Cory (Columbia University Health Sciences),200
Abbate Antonio (Virginia Commonwealth University),200
Abbott Derek W (Case Western Reserve University),200
Abbott Geoffrey W (University Of California-Irvine),200
Abdel-Mageed Asim B (Tulane University Of Louisiana),200
Abdellatif Maha (Rbhs-New Jersey Medical School),200
Abdul-Ghani Muhammad (University Of Texas Hsc San Antonio),200
Abdulkadir Sarki A (Northwestern University At Chicago),200

==> NIH_Funded_PIs_2017_Human_AutoRIF_counts.csv <==
Pathway,Count
Aakalu Vinay (University Of Illinois At Chicago),6
Aarons Gregory (University Of California San Diego),8
Aaronson Stuart A (Icahn School Of Medicine At Mount Sinai),100
Abaci Hasan Erbil (Columbia University Health Sciences),7
Abadir Peter M (Johns Hopkins University),5
Abais-Battad Justine M (Medical College Of Wisconsin),7
Aballay Alejandro (Duke University),13
Abate-Shen Cory (Columbia University Health Sciences),54
Abbate Antonio (Virginia Commonwealth University),97

==> NIH_Funded_PIs_2017_Human_GeneRIF_counts.csv <==
Pathway,Count
Aaronson Stuart A (Icahn School Of Medicine At Mount Sinai),27
Abate-Shen Cory (Columbia University Health Sciences),15
Abbate Antonio (Virginia Commonwealth University),16
Abbott Derek W (Case Western Reserve University),14
Abbott Geoffrey W (University Of California-Irvine),9
Abdel-Mageed Asim B (Tulane University Of Louisiana),29
Abdellatif Maha (Rbhs-New Jersey Medical School),5
Abdul-Ghani Muhammad (University Of Texas Hsc San Antonio),8
Abdulkadir Sarki A (Northwestern University At Chicago),11

==> Old_CMAP_down_counts.csv <==
Pathway,Count
ascorbic acid-1610,100
mianserin-1385,100
PF-00875133-00-5967,100
thalidomide-5990,100
carbenoxolone-3353,100
trimethadione-4086,100
diphenylpyraline-2205,100
ribavirin-6521,100
prilocaine-2314,100

==> Old_CMAP_up_counts.csv <==
Pathway,Count
ascorbic acid-1610,100
mianserin-1385,100
PF-00875133-00-5967,100
thalidomide-5990,100
carbenoxolone-3353,100
trimethadione-4086,100
diphenylpyraline-2205,100
ribavirin-6521,100
prilocaine-2314,100

==> OMIM_Disease_counts.csv <==
Pathway,Count
adenoma,14
alopecia,11
alzheimer disease,26
anemia,61
aneurysm,18
anomalies,13
arrhythmogenic right ventricular dysplasia,13
asthma,23
ataxia,60

==> OMIM_Expanded_counts.csv <==
Pathway,Count
adenocarcinoma,83
adenoma,80
adrenoleukodystrophy,83
aids,84
albinism,86
alopecia,88
alzheimer disease,103
amelogenesis imperfecta,84
amyloidosis,84

==> Orphanet_Augmented_2021_counts.csv <==
Pathway,Count
12p12.1 microdeletion syndrome ORPHA:313884,101
12q14 microdeletion syndrome ORPHA:94063,102
12q15q21.1 microdeletion syndrome ORPHA:289513,101
14q11.2 microduplication syndrome ORPHA:261229,101
15q11q13 microduplication syndrome ORPHA:238446,101
15q13.3 microdeletion syndrome ORPHA:199318,101
15q14 microdeletion syndrome ORPHA:261190,101
15q24 microdeletion syndrome ORPHA:94065,101
16p13.2 microdeletion syndrome ORPHA:500055,101

==> Panther_2015_counts.csv <==
Pathway,Count
5-Hydroxytryptamine degredation,5
5-arachidonylglycerol biosynthesis,6
5HT1 type receptor mediated signaling pathway,27
5HT2 type receptor mediated signaling pathway,30
5HT3 type receptor mediated signaling pathway,13
5HT4 type receptor mediated signaling pathway,16
Adenine and hypoxanthine salvage pathway,5
Adrenaline and noradrenaline biosynthesis,25
Alpha adrenergic receptor signaling pathway,23

==> Panther_2016_counts.csv <==
Pathway,Count
Androgen/estrogene/progesterone biosynthesis Homo sapiens P02727,8
ATP synthesis Homo sapiens P02721,5
Blood coagulation Homo sapiens P00011,38
Plasminogen activating cascade Homo sapiens P00050,15
Ubiquitin proteasome pathway Homo sapiens P00060,43
Cell cycle Homo sapiens P00013,16
Parkinson disease Homo sapiens P00049,81
Apoptosis signaling pathway Homo sapiens P00006,102
FAS signaling pathway Homo sapiens P00020,31

==> PFOCR_Pathways_2023_counts.csv <==
Pathway,Count
PMC102186 F9,7
PMC1064894 F3,11
PMC1069621 F5,6
PMC1083688 F2,5
PMC1087229 F8,6
PMC1087506 F8,7
PMC1124928 F4,6
PMC1140402 F2,5
PMC1143566 F2,5

==> PFOCR_Pathways_counts.csv <==
Pathway,Count
PMC102186 Mb2400926009,6
PMC1064894 Ar1469-3,10
PMC1069621 Zmb0080549030005,5
PMC1087229 Zmk0050531440008,5
PMC1087506 1465-9921-6-26-8,6
PMC1174965 Ar1741-4,5
PMC1175050 Ar1784-1,6
PMC1183194 1471-2407-5-74-4,11
PMC1183194 1471-2407-5-74-5,15

==> PhenGenI_Association_2021_counts.csv <==
Pathway,Count
1-Alkyl-2-acetylglycerophosphocholine Esterase,24
"13,16,19-Docosatrienoic Acid",34
25-Hydroxyvitamin D 2,52
3-Hydroxy-1-Methylpropylmercapturic Acid,335
AIDS Dementia Complex,7
Abdominal Fat,33
Acceleration,27
Acetaminophen,8
Acne Vulgaris,28

==> PheWeb_2019_counts.csv <==
Pathway,Count
ASCVD,15
Abdominal hernia,19
Abdominal pain,31
Abnormal Papanicolaou smear of cervix and cervical HPV,31
Abnormal chest sounds,14
Abnormal coagulation profile,23
Abnormal electrocardiogram [ECG] [EKG],29
Abnormal findings examination of lungs,14
Abnormal findings on mammogram or breast exam,36

==> PPI_Hub_Proteins_counts.csv <==
Pathway,Count
CALM3,172
PTPN11,168
CDK1,659
SPP382,145
HMT1,175
PCNA,146
DIPA,134
HTA2,172
XRCC6,141

==> ProteomicsDB_2020_counts.csv <==
Pathway,Count
Mixed PDB:200045 4Skin mix1 4Skin Fibro,371
Mixed PDB:200045 4Skin mix1 4Skin iPS,365
Mixed PDB:200045 4Skin mix2 4Skin Fibro,445
Mixed PDB:200045 4Skin mix2 4Skin iPS,445
Mixed PDB:200045 IMR90 mix1 IMR90 Fibro,223
Mixed PDB:200045 IMR90 mix1 IMR90 iPS,223
Mixed PDB:200045 gcpool scxfrac rep1,138
Mixed PDB:200045 gcpool scxfrac rep2,200
Mixed PDB:200045 gcpool sdsfrac rep1,224

==> Proteomics_Drug_Atlas_2023_counts.csv <==
Pathway,Count
SR 142948 Up,145
SR 142948 Down,142
UK 356618 Up,145
UK 356618 Down,147
JW 480 Up,143
JW 480 Down,141
ML-265 Up,145
ML-265 Down,146
PF-04418948 Up,147

==> Rare_Diseases_AutoRIF_ARCHS4_Predictions_counts.csv <==
Pathway,Count
11-beta-hydroxylase deficiency,200
15q13.3 microdeletion syndrome,200
16p11.2 deletion syndrome,200
17-alpha-hydroxylase deficiency,200
17-beta hydroxysteroid dehydrogenase 3 deficiency,200
17q21.31 microdeletion syndrome,200
1q21.1 microdeletion syndrome,200
2-Hydroxyglutaric aciduria,200
2-Methylacetoacetyl CoA thiolase deficiency,200

==> Rare_Diseases_AutoRIF_Gene_Lists_counts.csv <==
Pathway,Count
11-beta-hydroxylase deficiency,22
15q13.3 microdeletion syndrome,16
16p11.2 deletion syndrome,41
17-alpha-hydroxylase deficiency,21
17-beta hydroxysteroid dehydrogenase 3 deficiency,5
17q21.31 microdeletion syndrome,17
1q21.1 microdeletion syndrome,22
2-Hydroxyglutaric aciduria,32
2-Methylacetoacetyl CoA thiolase deficiency,93

==> Rare_Diseases_GeneRIF_ARCHS4_Predictions_counts.csv <==
Pathway,Count
15q13.3 microdeletion syndrome,200
2-Hydroxyglutaric aciduria,200
2-Methylacetoacetyl CoA thiolase deficiency,200
21-hydroxylase deficiency,200
22q11.2 deletion syndrome,200
3 methylglutaconic aciduria type I,200
3p deletion syndrome,200
46 XX testicular disorder of sex development,200
5-Nucleotidase syndrome,200

==> Rare_Diseases_GeneRIF_Gene_Lists_counts.csv <==
Pathway,Count
15q13.3 microdeletion syndrome,5
2-Hydroxyglutaric aciduria,6
2-Methylacetoacetyl CoA thiolase deficiency,10
21-hydroxylase deficiency,27
22q11.2 deletion syndrome,74
3 methylglutaconic aciduria type I,6
3p deletion syndrome,13
46 XX testicular disorder of sex development,6
5-Nucleotidase syndrome,6

==> Reactome_2013_counts.csv <==
Pathway,Count
3' -UTR-mediated translational regulation,103
APC-Cdc20 mediated degradation of Nek2A,19
APC/C:Cdh1-mediated degradation of Skp2,57
Activation of Cdc25A by c-myc,1
Apoptosis,117
Axon guidance,35
Biological oxidations,119
Botulinum neurotoxicity,16
Breakdown of hydrogen peroxide to water and molecular oxygen,1

==> Reactome_2015_counts.csv <==
Pathway,Count
2-LTR circle formation,7
3' -UTR-mediated translational regulation,104
A tetrasaccharide linker sequence is required for GAG synthesis,26
A third proteolytic cleavage releases NICD,9
ABC-family proteins mediated transport,36
ABCA transporters in lipid homeostasis,17
ADP signalling through P2Y purinoceptor 1,25
ADP signalling through P2Y purinoceptor 12,22
AKT phosphorylates targets in the cytosol,13

==> Reactome_2016_counts.csv <==
Pathway,Count
DNA Damage Reversal Homo sapiens R-HSA-73942,6
Reversal of alkylation damage by DNA dioxygenases Homo sapiens R-HSA-73943,5
Sperm:Oocyte Membrane Binding Homo sapiens R-HSA-1300652,5
Sperm Motility And Taxes Homo sapiens R-HSA-1300642,9
Fertilization Homo sapiens R-HSA-1187000,26
Reproduction Homo sapiens R-HSA-1474165,26
Interaction With The Zona Pellucida Homo sapiens R-HSA-1300644,10
Vitamin C (ascorbate) metabolism Homo sapiens R-HSA-196836,8
Facilitative Na+-independent glucose transporters Homo sapiens R-HSA-428790,13

==> Reactome_2022_counts.csv <==
Pathway,Count
2-LTR Circle Formation R-HSA-164843,8
GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,26
ABC Transporter Disorders R-HSA-5619084,77
ABC Transporters In Lipid Homeostasis R-HSA-1369062,18
ABC-family Proteins Mediated Transport R-HSA-382556,102
ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,131
ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,25
ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,22
AKT Phosphorylates Targets In Cytosol R-HSA-198323,14

==> RNAseq_Automatic_GEO_Signatures_Human_Down_counts.csv <==
Pathway,Count
Circrna Gallbladder Compared Matched GSE100363 1,250
Inversion Ctcf Alters Topology GSE71275 1,250
Ar-Wt Ligand-Independent Ar-V7 Splice GSE71334 1,250
Ehmt1 Ehmt2 Fetal Hemoglobin GSE71421 1,250
Prolyl Hydroxylation Synthesis Cardiomyocytes GSE71560 1,250
Fus Sequencing Anti-Fus Immunoprecipitation GSE71812 1,250
Gata3-Mediated Chromatin Reprogramming Breast GSE72141 1,250
Ro60 Autoantigen Binds Retroelements GSE72420 1,250
Moderate Dysplasia Mucosa Conversion GSE72627 1,250

==> RNAseq_Automatic_GEO_Signatures_Human_Up_counts.csv <==
Pathway,Count
Circrna Gallbladder Compared Matched GSE100363 1,250
Inversion Ctcf Alters Topology GSE71275 1,250
Ar-Wt Ligand-Independent Ar-V7 Splice GSE71334 1,250
Ehmt1 Ehmt2 Fetal Hemoglobin GSE71421 1,250
Prolyl Hydroxylation Synthesis Cardiomyocytes GSE71560 1,250
Fus Sequencing Anti-Fus Immunoprecipitation GSE71812 1,250
Gata3-Mediated Chromatin Reprogramming Breast GSE72141 1,250
Ro60 Autoantigen Binds Retroelements GSE72420 1,250
Moderate Dysplasia Mucosa Conversion GSE72627 1,250

==> RNAseq_Automatic_GEO_Signatures_Mouse_Down_counts.csv <==
Pathway,Count
Tet2 Dysregulates Behavior Stromal GSE100071 1,250
Perturbation Ogt-Tet1 Interaction Embryonic GSE109540 1,250
Pja2 P2Rx3 P2Rx7 Axis GSE109699 1,250
Insm1 Delamination Down-Regulation Adherens GSE109709 1,250
Effect Er-464195-01 Gene Intestine GSE109728 1,250
Expression Profiles Cd4Low Hla-G GSE109844 1,250
Bi-Directional Mesenchymal Transit Axin2Beta GSE109877 1,250
Kdm6B Self-Renewal Leukemic Proliferative GSE110378 1,250
Cell-Mediated Cytotoxicity Cytostatic Drug GSE110397 1,250

==> RNAseq_Automatic_GEO_Signatures_Mouse_Up_counts.csv <==
Pathway,Count
Tet2 Dysregulates Behavior Stromal GSE100071 1,250
Perturbation Ogt-Tet1 Interaction Embryonic GSE109540 1,250
Pja2 P2Rx3 P2Rx7 Axis GSE109699 1,250
Insm1 Delamination Down-Regulation Adherens GSE109709 1,250
Effect Er-464195-01 Gene Intestine GSE109728 1,250
Expression Profiles Cd4Low Hla-G GSE109844 1,250
Bi-Directional Mesenchymal Transit Axin2Beta GSE109877 1,250
Kdm6B Self-Renewal Leukemic Proliferative GSE110378 1,250
Cell-Mediated Cytotoxicity Cytostatic Drug GSE110397 1,250

==> RNA-Seq_Disease_Gene_and_Drug_Signatures_from_GEO_counts.csv <==
Pathway,Count
17-betaestradiol Oviduct epithelial cell line 1 nM GSE67207 down,497
17-betaestradiol Oviduct epithelial cell line 1 nM GSE67207 up,496
"2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) Primary B cell 30 nM 24 hr GSE80953 down",494
"2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) Primary B cell 30 nM 24 hr GSE80953 up",495
"2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) Primary B cell 30 nM 4 hr GSE80953 down",491
"2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) Primary B cell 30 nM 4 hr GSE80953 up",496
"2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) Primary B cell 30 nM 8 hr GSE80953 down",497
"2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) Primary B cell 30 nM 8 hr GSE80953 up",488
4-hydroxytamoxifen Embrionic stem cells 0.1 uM 0 hrs GSE84953 down,497

==> Table_Mining_of_CRISPR_Studies_counts.csv <==
Pathway,Count
"Icaro, PMC6406408 (Table1)",10
PMC6723146 (Table1),12
PMC6723146 (Table2),13
PMC6723146 (Table3),16
"Accession refseq lcn numbers ncbi, PMC6381713 (Table1)",19
"Actionable unique pairs drug recommended, PMC5085745 (Table1)",21
"Activity target analysis, PMC5328670 (Table1)",13
"Adjusted values al et listed, PMC6042961 (Table1)",27
"Adk mda mb line knockdown, PMC6944449 (Table1)",18

==> Tabula_Muris_counts.csv <==
Pathway,Count
B Cell Spleen CL:0000236,79
T Cell Spleen CL:0000084,83
Myeloid Cell Spleen CL:0000763,65
Basal Cell Mammary CL:0000646,93
Endothelial Cell Mammary CL:0000115,84
Luminal Epithelial Cell Mammary Gland Mammary CL:0002326,88
Stromal Cell Mammary CL:0000499,90
T Cell Thymus CL:0000084,91
Mesenchymal Stem Cell Thymus CL:0000134,73

==> Tabula_Sapiens_counts.csv <==
Pathway,Count
Bladder-bladder Urothelial Cell,100
Bladder-capillary Endothelial Cell,100
Bladder-endothelial Cell Of Lymphatic Vessel,99
Bladder-fibroblast,100
Bladder-macrophage,100
Bladder-mast Cell,100
Bladder-myofibroblast Cell,100
Bladder-nk Cell,100
Bladder-pericyte Cell,100

==> TargetScan_microRNA_2017_counts.csv <==
Pathway,Count
mmu-miR-467a,1739
hsa-miR-4749-5p,1198
hsa-miR-4467,803
hsa-miR-154,1842
mmu-miR-875-5p,1131
hsa-miR-4278,1632
mmu-miR-126-3p,124
hsa-miR-525-3p,464
hsa-miR-4520b-3p,1938

==> TargetScan_microRNA_counts.csv <==
Pathway,Count
"ACTGTGA,MIR-27A,MIR-27B",476
"GTTTGTT,MIR-495",258
"AGGGCAG,MIR-18A",138
"ATGTAGC,MIR-221,MIR-222",140
"ACTGAAA,MIR-30A-3P,MIR-30E-3P",203
"GAGCCAG,MIR-149",146
"TCCGTCC,MIR-184",13
"CCTGCTG,MIR-214",242
"TGGTGCT,MIR-29A,MIR-29B,MIR-29C",521

==> TF-LOF_Expression_from_GEO_counts.csv <==
Pathway,Count
cebpa 22442349 pbmc lof human gpl570 gds4407 up,438
egr1 20019881 retina lof mouse gpl1261 gds3607 down,176
hnf1b 16297991 hek293 embryonic gof mouse gpl96 gds1499 down,103
nfe2l2 23639809 whole esophagus lof mouse gpl7202 gse39629 up,881
nfe2l2 2383093 whole skin gof mouse gpl1261 gse35160 up,99
gata4 21746915 heart lof mouse gpl6246 gds3931 down,255
cdx2 21402776 jejunum epithelium lof mouse gpl11044 gse24633 up,118
tcf3 21972416 linnegflt3poscd127posly6dneg bone marrow lof mouse gpl1261 gse27402 up,288
znf217 22593193 mda mb 231 gof human gpl570 gse35511 up,922

==> TF_Perturbations_Followed_by_Expression_counts.csv <==
Pathway,Count
NR3C1 KO MOUSE GSE23724 CREEDSID GENE 3014 UP,213
MEF2D KD MOUSE GSE47150 CREEDSID GENE 366 UP,281
KCNIP3 KO MOUSE GSE16874 CREEDSID GENE 1031 UP,245
RUNX1 KO MOUSE GSE2592 CREEDSID GENE 277 UP,274
OVOL1 KO MOUSE GSE55072 CREEDSID GENE 2617 UP,270
RARA KD HUMAN GSE26298 CREEDSID GENE 69 UP,290
TCF12 KO MOUSE GSE27402 CREEDSID GENE 2168 UP,315
MYB KD HUMAN GSE49286 CREEDSID GENE 1835 UP,333
MYOD1 MUT MOUSE GSE6487 CREEDSID GENE 1178 UP,229

==> TG_GATES_2020_counts.csv <==
Pathway,Count
14d AAA,914
14d AAF,2307
14d AA,102
14d ACA,60
14d ACZ,125
14d ADP,27
14d AJM,141
14d AMB,51
14d AMT,365

==> The_Kinase_Library_2023_counts.csv <==
Pathway,Count
AAK1,744
ACVR2A,701
ACVR2B,690
AKT1,877
AKT2,867
AKT3,847
ALK2,678
ALK4,709
ALPHAK3,751

==> Tissue_Protein_Expression_from_Human_Proteome_Map_counts.csv <==
Pathway,Count
adult adrenal,301
adult colon,301
adult esophagus,301
adult frontal cortex,301
adult gallbladder,301
adult heart,301
adult kidney,301
adult liver,301
adult lung,301

==> Tissue_Protein_Expression_from_ProteomicsDB_counts.csv <==
Pathway,Count
A-375 cell,301
A-498 cell,301
A-549 cell,301
ACHN cell,301
B-lymphocyte,301
BICR16,301
BICR56,301
BT-474 cell,301
BT-549 cell,301

==> Transcription_Factor_PPIs_counts.csv <==
Pathway,Count
SMARCC2,114
HSF1,109
EGR1,35
ZFPM2,15
FOXA1,10
CDKN2AIP,14
CDX2,17
NELFE,6
SMARCC1,114

==> TRANSFAC_and_JASPAR_PWMs_counts.csv <==
Pathway,Count
Gata1 (mouse),1863
Tcfcp2l1 (mouse),17
Stat3 (mouse),1762
TP63 (human),1443
NFE2L2 (human),84
MZF1 (human),1389
MYC (mouse),1699
POU2F1 (human),1399
RUNX1 (mouse),53

==> TRRUST_Transcription_Factors_2019_counts.csv <==
Pathway,Count
AATF mouse,6
ABL1 human,10
AHR human,22
AHR mouse,22
APC human,12
APEX1 human,7
APEX1 mouse,8
AR human,93
AR mouse,13

==> UK_Biobank_GWAS_v1_counts.csv <==
Pathway,Count
2005 nitrogen dioxide air pollution 24016 raw,4
2006 nitrogen dioxide air pollution 24017 raw,3
2007 particulate matter air pollution (pm10) 24019 raw,8
A/AS levels or equivalent 6138 2,86
Able to confide 2110,12
Able to pay rent/mortgage as an adult 20525,7
Accpeted invitation to complete dietary questionnaire 110001,4
Added milk to filtered coffee 100280,4
Adult-onset Still disease STILL ADULT,7

==> Virus-Host_PPI_P-HIPSTer_2020_counts.csv <==
Pathway,Count
Adeno-associated virus - 2 Rep 52 protein,9
Adeno-associated virus - 2 major coat protein VP3,26
Adeno-associated virus - 2 major coat protein VP2,26
Adeno-associated virus - 2 Rep 40 protein,9
Adeno-associated virus - 2 assembly activating protein AAP,7
Adeno-associated virus - 2 Rep 68 protein,20
Adeno-associated virus - 2 major coat protein VP1,28
Adeno-associated virus - 2 Rep 78 protein,20
Adeno-associated virus - 3 capsid protein,28

==> VirusMINT_counts.csv <==
Pathway,Count
JC polyomavirus,2
Sendai virus (strain Fushimi),1
Bovine papillomavirus type 1,28
Human cytomegalovirus,1
Bovine papillomavirus type 2,1
Hepatitis delta virus (isolate D380),1
Human herpesvirus 1,4
Human immunodeficiency virus type 1 (isolate HXB3),2
Vaccinia virus (strain L-IVP),7

==> Virus_Perturbations_from_GEO_down_counts.csv <==
Pathway,Count
A-CA-04-2009(H1N1)MA Day1 GSE36328,300
A-CA-04-2009(H1N1)MA Day3 GSE36328,300
A-CA-04-2009(H1N1) 0Hour GSE47960,300
A-CA-04-2009(H1N1) 0Hour GSE47961,300
A-CA-04-2009(H1N1) 0Hour GSE47962,300
A-CA-04-2009(H1N1) 0Hour GSE37571,300
A-CA-04-2009(H1N1) 0Hour GSE40844,300
A-CA-04-2009(H1N1) 12Hour GSE47960,300
A-CA-04-2009(H1N1) 12Hour GSE47961,300

==> Virus_Perturbations_from_GEO_up_counts.csv <==
Pathway,Count
A-CA-04-2009(H1N1)MA Day1 GSE36328,300
A-CA-04-2009(H1N1)MA Day3 GSE36328,300
A-CA-04-2009(H1N1) 0Hour GSE47960,300
A-CA-04-2009(H1N1) 0Hour GSE47961,300
A-CA-04-2009(H1N1) 0Hour GSE47962,300
A-CA-04-2009(H1N1) 0Hour GSE37571,300
A-CA-04-2009(H1N1) 0Hour GSE40844,300
A-CA-04-2009(H1N1) 12Hour GSE47960,300
A-CA-04-2009(H1N1) 12Hour GSE47961,300

==> WikiPathway_2021_Human_counts.csv <==
Pathway,Count
15q11.2 copy number variation syndrome WP4940,9
15q13.3 copy number variation syndrome WP4942,19
16p11.2 distal deletion syndrome WP4950,31
16p11.2 proximal deletion syndrome WP4949,74
1q21.1 copy number variation syndrome WP4905,27
22q11.2 copy number variation syndrome WP4657,131
3q29 copy number variation syndrome WP4906,63
"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",18
7-oxo-C and 7beta-HC pathways WP5064,27

==> WikiPathway_2021_Mouse_counts.csv <==
Pathway,Count
ACE Inhibitor Pathway WP396,9
Acetylcholine Synthesis WP175,7
Adipogenesis genes WP447,134
Aflatoxin B1 metabolism WP1262,5
Alanine and aspartate metabolism WP240,15
Alpha6-Beta4 Integrin Signaling Pathway WP488,67
Alzheimer's disease WP2075,75
Amino Acid metabolism WP662,95
ApoE and miR-146 in inflammation and atherosclerosis WP3592,8

==> WikiPathways_2013_counts.csv <==
Pathway,Count
Hs ACE Inhibitor Pathway WP554 22578,5
Hs ACE Inhibitor Pathway WP554 30178,5
Hs Acetylcholine Synthesis WP528 29049,7
Hs Adipogenesis WP236 28133,112
Hs Alanine and aspartate metabolism WP106 20905,12
Hs Alpha6-Beta4 Integrin Signaling Pathway WP244 21193,63
Hs amino acid conjugation of benzoic acid WP521 29685,1
Hs Androgen Receptor Signaling Pathway WP138 20973,99
Hs Apoptosis Modulation by HSP70 WP384 21486,13

==> WikiPathways_2015_counts.csv <==
Pathway,Count
ACE Inhibitor Pathway(Homo sapiens),17
ACE Inhibitor Pathway(Mus musculus),8
AGE/RAGE pathway(Homo sapiens),66
AMPK Signaling(Homo sapiens),69
ATM Signaling Pathway(Homo sapiens),40
Acetylcholine Synthesis(Homo sapiens),7
Acetylcholine Synthesis(Mus musculus),6
Adipogenesis genes(Mus musculus),129
Adipogenesis(Homo sapiens),134

==> WikiPathways_2016_counts.csv <==
Pathway,Count
Heme Biosynthesis Homo sapiens WP561,9
Heme Biosynthesis Mus musculus WP18,9
Deregulation of Rab and Rab Effector Genes in Bladder Cancer Homo sapiens WP2291,16
Arachidonate Epoxygenase / Epoxide Hydrolase Homo sapiens WP678,7
Electron Transport Chain Mus musculus WP295,93
Electron Transport Chain Homo sapiens WP111,103
Oxidative phosphorylation Homo sapiens WP623,60
Oxidative phosphorylation Mus musculus WP1248,53
Striated Muscle Contraction Homo sapiens WP383,38

==> WikiPathways_2019_Human_counts.csv <==
Pathway,Count
"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",18
ACE Inhibitor Pathway WP554,17
AGE/RAGE pathway WP2324,66
AMP-activated Protein Kinase (AMPK) Signaling WP1403,69
ATM Signaling Network in Development and Disease  WP3878,45
ATM Signaling Pathway WP2516,40
ATR Signaling WP3875,9
Acetylcholine Synthesis WP528,7
Adipogenesis WP236,130

==> WikiPathways_2019_Mouse_counts.csv <==
Pathway,Count
ACE Inhibitor Pathway WP396,9
Acetylcholine Synthesis WP175,7
Adipogenesis genes WP447,134
Aflatoxin B1 metabolism WP1262,5
Alanine and aspartate metabolism WP240,15
Alpha6-Beta4 Integrin Signaling Pathway WP488,67
Alzheimers Disease WP2075,75
Amino Acid metabolism WP662,95
ApoE and miR-146 in inflammation and atherosclerosis WP3592,8
